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Abstract The comprehensive understanding of cellular signaling pathways remains a challenge
due to multiple layers of regulation that may become evident only when the pathway is probed at
different levels or critical nodes are eliminated. To discover regulatory mechanisms in canonical
WNT signaling, we conducted a systematic forward genetic analysis through reporter-based
screens in haploid human cells. Comparison of screens for negative, attenuating and positive
regulators of WNT signaling, mediators of R-spondin-dependent signaling and suppressors of
constitutive signaling induced by loss of the tumor suppressor adenomatous polyposis coli or
casein kinase 1a uncovered new regulatory features at most levels of the pathway. These include a
requirement for the transcription factor AP-4, a role for the DAX domain of AXIN2 in controlling b-
catenin transcriptional activity, a contribution of glycophosphatidylinositol anchor biosynthesis and
glypicans to R-spondin-potentiated WNT signaling, and two different mechanisms that regulate
signaling when distinct components of the b-catenin destruction complex are lost. The conceptual




Cellular signaling systems have evolved complex circuitry involving multiple layers of regulation,
making their comprehensive characterization a major challenge. Forward genetics in model organ-
isms has been a general and unbiased way to identify new components in signaling pathways and to
map their connectivity. However, since signaling pathways have often diverged between humans
and these simpler model systems, their analysis in human cells becomes an important goal. Indeed,
our ability to identify the best therapeutic strategy or to predict the effectiveness of drugs targeting
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specific proteins is often hampered by an incomplete understanding of signaling circuitry in human
cells (Lito et al., 2013). Recent methodological advances have enabled the interrogation of biologi-
cal processes in human cells through powerful genome-wide screens that overcome many of the lim-
itations associated with previous platforms (Carette et al., 2009; Gilbert et al., 2014;
Shalem et al., 2014; Wang et al., 2014). Yet, inferring functional relationships in complex pathways
from such screens remains a major obstacle that has only recently began to be addressed
(Bassik et al., 2013; Blomen et al., 2015; Parnas et al., 2015; Wang et al., 2015).
Genetics has long relied on the use of sensitized backgrounds, modifier screens and synthetic
effects to uncover the myriad layers of regulation in signaling pathways. We reasoned that one way
to discover both epistatic relationships on a genome scale and unique context-specific requirements
would be through the quantitative comparison of genome-wide screens in which the pathway is acti-
vated by different ligands, and of suppressor screens following targeted disruption of critical nodes.
We took advantage of two methodologies to conduct a systematic genetic analysis of WNT signaling
in human cells: forward genetics in haploid cells using gene trap (GT)-based insertional mutagenesis
(Carette et al., 2009), and targeted genome engineering by clustered regularly-interspaced short
palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) (Cong et al., 2013; Mali et al.,
2013).
eLife digest When an embryo is developing, its cells must communicate with one another to
coordinate the processes that shape the body’s tissues and organs. Cells often communicate by
releasing signaling molecules that engage with proteins called receptors on the surface of other
cells. This triggers a series of events that sends the signal along a “pathway” of biochemical
reactions inside the receiving cell and leads to the activation of genes. One such signaling pathway
is triggered by the WNT proteins and is used extensively in all animals. The WNT pathway instructs
cells to grow and divide, establishes the identity of specific cell types and maintains populations of
stem cells that can regenerate tissues in adulthood as well. The WNT pathway must be carefully
regulated because various types of cancer can develop if the pathway becomes too active.
Some signaling pathways are well conserved between different animals. Many genetic studies
into the WNT pathway have focused on animals that are easier to work with in the laboratory, like
worms or flies. However, there may be differences in the way these pathways are regulated between
these model animals and humans. Therefore, to understand how the WNT pathway operates in
humans, it was important to study it in human cells too.
Lebensohn et al. have now carried out a series of genetic screens in human cells that contain only
one copy of each gene instead of the usual two. These cells – referred to as haploid cells – are ideal
for genetic studies because only a single copy of a gene has to be disrupted in order to analyze the
consequences of that gene’s loss. The screens searched for genes that regulate WNT signaling:
those that keep the pathway “off” in the absence of WNT and those that turn the pathway “on” in
response to WNT.
By comparing the outcomes of these screens, Lebensohn et al. identified previously unknown
regulators and uncovered new roles for known regulators of the WNT pathway. For instance, a
regulator called TFAP4, which had not previously been linked to the pathway, was shown to activate
WNT signaling. In another case, enzymes that make molecules called glycophosphatidylinositol
anchors, and cell-surface proteins that are modified with those anchors, were found to amplify WNT
signaling.
Lebensohn et al. also identified genes that were needed to sustain the uncontrolled WNT
signaling in cells that carried cancer-causing mutations in this pathway. Further studies could now
explore if drugs can target these genes, or the molecules encoded by them, to treat cancers in
which the WNT pathway is excessively activated. Other studies could also use the same methods to
explore more signaling pathways and gain new insights into important biological processes in
human cells.
DOI: 10.7554/eLife.21459.002
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Figure 1. Reporter-based, forward genetic screens in haploid human cells identify negative, attenuating and positive regulators of WNT signaling. (A)
Schematic model of canonical WNT signaling, highlighting the main pathway components and regulatory events in the absence (left panel) and
presence (center panel) of ligands, and other known regulators relevant to this work (right panel). When the pathway is off, the transcriptional co-
activator b-catenin (CTNNB1) is constitutively targeted for proteasomal degradation by the destruction complex, composed of the scaffold proteins
Figure 1 continued on next page
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The WNT pathway is a fundamental signaling system that plays central roles in embryonic devel-
opment, regeneration and cancer (reviewed in Hoppler and Moon, 2014). During development,
WNT signaling orchestrates transcriptional programs that regulate cell proliferation and survival, cell
fate determination, and tissue patterning. In adults, WNT signaling is instrumental in defining stem
cell niches in multiple organs, which maintain tissue homeostasis during routine turnover or following
injury. Overactive WNT signaling can be oncogenic, driving both the initiation and maintenance of
various types of cancer, most notably colorectal cancer (CRC).
While the pathway has been studied intensively (we provide a snapshot in Figure 1A and refer
readers to the legend for details), critical steps remain poorly understood even 34 years after the dis-
covery of ‘int1’, as mammalian WNT was initially called (Nusse and Varmus, 1982). The complex cir-
cuitry of the pathway may mask unknown regulatory mechanisms overlaid on the core module,
making it an ideal system for an in-depth, methodical genetic dissection, extending a rich tradition
of genetic studies (Nüsslein-Volhard and Wieschaus, 1980). Known pathway components would
serve to benchmark any new discoveries, and new discoveries would likely have important therapeu-
tic implications due to the pathway’s direct relevance to stem cell biology and cancer.
We initially probed the intact pathway through genome-wide, forward genetic screens for nega-
tive, attenuating and positive regulators to define the basic set of genes required for signaling in
haploid human cells. We identified many of the known core pathway components and found a new
requirement for the transcription factor AP-4 (TFAP4). Unexpectedly, these screens uncovered a
dominant allele of AXIN2 that dissociated b-catenin (CTNNB1) protein stabilization, considered the
decisive event in WNT signaling, from its transcriptional activity. To find factors required for amplifi-
cation of WNT responses by R-spondins (RSPOs, Figure 1A), we devised a sensitized screen for
RSPO-enhanced WNT signaling and uncovered a requirement for the glycophosphatidylinositol
(GPI) anchor biosynthetic machinery and glypicans. Finally, we searched for mutations that could
suppress constitutive signaling in cells with compromised function of the CTNNB1 destruction com-
plex, recapitulating the most common defect in oncogenic WNT signaling. Suppressor screens in
cells lacking adenomatous polyposis coli (APC) or casein kinase 1a (CSNK1A1), the two rate-limiting
negative regulators of the pathway in haploid cells, revealed two distinct mechanisms that regulate
CTNNB1 abundance and transcriptional activity, respectively. One mechanism was specific to cells
Figure 1 continued
adenomatous polyposis coli (APC) and AXIN, and the kinases glycogen synthase kinase 3 (GSK3) and casein kinase 1a (CSNK1A1). The T-cell-specific
transcription factor (TCF)/lymphoid enhancer-binding factor (LEF) family of transcription factors, together with transducin like enhancer of split (TLE) and
histone deacetylases (HDAC), repress WNT target genes. Binding of WNT to its co-receptors frizzled (FZD) and low-density lipoprotein receptor-related
protein 6 (LRP6) leads to the assembly of a receptor complex that inactivates the destruction complex through a mechanism involving recruitment of
AXIN by LRP6 and the adapter protein dishevelled (DVL). Consequently, CTNNB1 accumulates in the cytoplasm, translocates to the nucleus and
promotes WNT target gene transcription in cooperation with TCF/LEF and other co-activators such as CREB-binding protein (CREBBP) and B-cell CLL/
lymphoma 9 protein (BCL9). R-spondins (RSPOs) are secreted proteins that potentiate the response of stem cells to WNT ligands by blocking the
degradation of FZD and LRP6 receptors. RSPO binds to leucine-rich repeat-containing G-protein-coupled receptors (LGRs) and neutralizes two
transmembrane E3 ubiquitin ligases, ZNRF3 and RNF43, that clear WNT receptors from the cell surface. Other regulatory mechanisms include
modulation of AXIN levels by the poly ADP-ribosylation-dependent E3 ubiquitin ligase RNF146, and recruitment of DOT1L and MLLT10, two proteins
involved in histone H3 K79 methylation, to WNT target genes. (B) Schematic of WNT reporter-based forward genetic screens in haploid human cells
using a GT-bearing retrovirus for mutagenesis, followed by phenotypic enrichment by FACS. LTR, long terminal repeats; SA, splice acceptor; pA,
polyadenylation signal. (C–F) Circle plots depicting genes enriched for GT insertions in screens for negative (C), attenuating (D) and positive (E and F)
regulators of WNT signaling. Two independent screens for positive regulators were performed at low (E) and high (F) selection stringencies by sorting
for cells with the lowest 10% and 2% WNT reporter fluorescence, respectively. The y-axis indicates the significance of GT insertion enrichment in the
sorted vs. the control cells (expressed in units of -log10FDR-corrected p-value) and the x-axis indicates genes (in random order) for which GT insertions
were mapped in the sorted cells. Genes with FDR-corrected p-value<0.01 are labeled and colored in light blue if they encode a known pathway
component, or in pink if their product has not been previously implicated as a regulator of canonical WNT signaling. The diameter of each circle is
proportional to the number of unique inactivating GT insertions mapped in the sorted cells, which is also indicated next to the gene name for the most
significant hits with FDR-corrected p-values<10 4.
DOI: 10.7554/eLife.21459.003
The following figure supplement is available for figure 1:
Figure supplement 1. Characterization of HAP1-7TGP, a haploid human cell line harboring a WNT-responsive fluorescent reporter (A–D), and
depiction of FACS gates and phenotypic enrichment during various reporter-based forward genetic screens (E–H).
DOI: 10.7554/eLife.21459.004
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lacking CSNK1A1, but not APC, suggesting that different components of the destruction complex
have different functions in WNT signaling beyond their common function controlling CTNNB1 pro-
tein abundance.
Through a quantitative comparative analysis across seven screens, we confirmed epistatic rela-
tionships for known regulators and predicted them for new ones. The combined results of these
screens provide a comprehensive resource for understanding the regulation of canonical WNT
signaling.
Results
Forward genetic screens in haploid human cells identify negative,
attenuating, and positive regulators of WNT signaling
A central goal of this project was to search for quantitative and context-specific regulators of WNT
signaling in an unbiased and comprehensive manner. We adopted two design principles that
exploited the flexibility of forward genetics in cultured human cells. First, as a means of phenotypic
enrichment, we chose a fluorescence-based, quantitative transcriptional reporter of WNT signaling.
Since WNT reporter fluorescence is a continuous readout, in contrast to digital readouts such as cell
viability or the presence or absence of a phenotype, it enabled us to enrich for cells with enhanced
or reduced signaling phenotypes by fluorescence activated cell sorting (FACS) with complete flexibil-
ity on the stringency of selection. Second, all screens were performed in a pooled format following
genome-scale insertional mutagenesis using a GT-bearing retrovirus, which contains a strong splice
acceptor site and can therefore disrupt genes when it integrates in either exons or introns. This
mutagenesis method is untargeted, distinguishing it from approaches in which short hairpin RNAs or
single guide RNAs (sgRNAs) are designed to perturb a pre-defined set of cistrons.
We constructed and thoroughly characterized a clonal haploid human cell line, hereafter called
HAP1-7TGP, in which expression of enhanced green fluorescent protein (EGFP) is driven by an
established WNT-responsive element containing the seven TCF/LEF-binding sites, minimal promoter
and 5’UTR of the SuperTOPflash reporter (Fuerer and Nusse, 2010; Figure 1—figure supplement
1A–1D). While this construct has been used extensively to report on WNT responses, it may not
mimic all endogenous regulatory sequences driving WNT target gene expression. In particular, the
effects of proteins involved in modifying chromatin structure could differ between the reporter and
endogenous target genes. Given these limitations, whenever possible we confirmed new regulatory
mechanisms by measuring endogenous WNT target gene activity or assessing WNT-dependent phe-
notypes in model organisms.
To obtain saturating mutational coverage of the genome, we started our screens with 120 million
HAP1-7TGP cells (or engineered derivatives thereof) mutagenized with the GT retrovirus, ensuring
that the mutant cell population as a whole contained multiple (up to a few hundred) independent
lesions in every gene (Figure 1B). The screens should therefore capture most genes involved in the
phenotype being enriched for, except for genes required for the viability of haploid cells and genes
with redundant function, since the probability of independent GT integrations disrupting redundant
genes in the same haploid cell is vanishingly small. This limitation is inherent to all forward genetic
screens that use random or untargeted mutagenesis.
After sequential rounds of FACS-based phenotypic enrichment and growth (HAP1-7TGP cells do
not require WNT signaling for growth, enabling the propagation of cells with decreased or increased
WNT signaling activity following phenotypic enrichment), we mapped retroviral integration sites at
nucleotide resolution by deep sequencing an amplified library containing junctions between GTs
and flanking genomic DNA (Figure 1B; see Materials and methods). Sequence reads from the sorted
cells were compared to those from control, unsorted cells to identify genes enriched for GT inser-
tions in the sorted cell population. Disruption of these genes would be expected to cause the phe-
notype used as the basis for selection.
We devised a genome-wide screen to identify the rate-limiting negative regulators of WNT
signaling (i.e. genes whose disruption leads to constitutive pathway activity) in haploid human cells.
We used FACS to sort mutagenized HAP1-7TGP cells with high WNT reporter activity in the absence
of WNT ligand (‘EGFP+’ gate in Figure 1—figure supplement 1E). Following two rounds of sorting
(see Materials and methods), GT insertions in only three genes showed statistically significant (false
Lebensohn et al. eLife 2016;5:e21459. DOI: 10.7554/eLife.21459 5 of 40
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discovery rate (FDR)-corrected p-value<0.01)
enrichment in the sorted cells: CSNK1A1, APC
and PYY (Figure 1C and Supplementary file 1).
We mapped 144 independent GT insertions in
CSNK1A1 and 29 in APC, showing that our muta-
genesis had indeed targeted each gene multiple
times. CSNK1A1 and APC are core components
of the destruction complex that suppresses WNT
signaling by promoting CTNNB1 degradation
(Figure 1A); their identification as top hits reas-
sured us that our screening strategy could iden-
tify important regulators of canonical WNT
signaling. Genes encoding other known negative
regulators of the pathway, such as GSK3A and
GSK3B or AXIN1 and AXIN2, presumably did not
score as hits in this screen due to redundancy, as
suggested by their expression profile in HAP1
cells (Table 1). We demonstrate later that AXIN1
and AXIN2 are indeed functionally
redundant in HAP1 cells (Figure 3—figure sup-
plement 1B). The fact that APC, but not APC2,
was identified as a hit indicates that these two
genes are not redundant in HAP1 cells, a
conclusion that is supported by the relatively low
expression level of APC2 (Table 1).
To identify attenuating regulators of WNT sig-
naling (i.e. genes whose disruption amplifies cel-
lular responses to WNT ligands), we stimulated
mutagenized HAP1-7TGP cells with a sub-saturat-
ing dose of WNT3A (12.5% WNT3A conditioned
medium (CM), Figure 1—figure supplement 1B)
and sorted for cells with the highest 2% EGFP
fluorescence (‘highest 2%’ gate in Figure 1—fig-
ure supplement 1F). Following two rounds of
FACS sorting, three genes were significantly
enriched for GT insertions (Figure 1D and
Supplementary file 1). ZNRF3 was the top hit.
Eliminating ZNRF3 or RNF43, two transmem-
brane E3 ubiquitin ligases, has been shown to
amplify WNT signaling by increasing FZD and
LRP6 levels on the cell surface (Hao et al., 2012;
Koo et al., 2012; Figure 1A). Only ZNRF3 is
expressed at significant levels in HAP1 cells
(Table 1), explaining why it was a hit in this
screen. The second most significant hit of this
screen was TCF7L2, encoding a TCF/LEF family
transcription factor that can also function as
an attenuating regulator of WNT target genes
(Tang et al., 2008). Loss of either ZNRF3 or
TCF7L2 is predicted to potentiate signaling
responses rather than making them WNT-inde-
pendent, explaining why these genes did not
score in the negative regulator screen (Figure 1C
and Supplementary file 1). These findings high-
light one of the advantages of using a reporter
with a graded output: different regulatory layers
Table 1. Relative gene expression level of
selected WNT pathway regulators in HAP1 cells.
RPKM values from duplicate RNAseq datasets
generated as described in Materials and meth-
ods from two different passages of WT HAP1
cells are shown. Groups of paralogues and genes
with similar functions are shaded in alternating
colors to facilitate comparisons.
Gene
RPKM
Replicate 1 Replicate 2 Average
LGR4 160.61 174.69 167.65
LGR5 0.02 0.00 0.01
LGR6 0.02 0.00 0.01
ZNRF3 30.90 33.30 32.10
RNF43 0.12 0.08 0.10
LRP5 55.92 64.38 60.15
LRP6 109.51 121.08 115.30
FZD1 19.57 18.85 19.21
FZD2 19.56 21.09 20.33
FZD3 48.02 55.82 51.92
FZD4 19.60 22.10 20.85
FZD5 31.85 34.52 33.19
FZD6 33.53 31.95 32.74
FZD7 13.89 14.89 14.39
FZD8 4.02 4.48 4.25
FZD9 3.66 2.80 3.23
FZD10 10.40 9.86 10.13
DVL1 73.91 69.61 71.76
DVL2 51.74 48.80 50.27
DVL3 88.84 90.25 89.54
APC 80.47 85.22 82.84
APC2 2.94 3.69 3.32
AXIN1 55.97 54.07 55.02
AXIN2 10.04 12.51 11.27
CSNK1A1 111.18 109.57 110.37
GSK3A 75.97 69.21 72.59
GSK3B 62.79 69.98 66.39
TCF7L2 23.89 27.69 25.79
LEF1 12.34 14.80 13.57
CTNNB1 324.05 308.53 316.29
CREBBP 141.92 165.58 153.75
PIGL 4.07 4.51 4.29
GPC4 209.39 229.86 219.63
GPC6 13.88 14.90 14.39
TFAP4 36.99 41.94 39.46
SERBP1 721.65 698.99 710.32
HUWE1 631.58 777.06 704.32
DOI: 10.7554/eLife.21459.005
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in the pathway can be revealed by subtle alterations in selection conditions.
In a screen for positive regulators of canonical WNT signaling (i.e. genes whose disruption
reduces signaling output), we stimulated mutagenized HAP1-7TGP cells with a near-saturating dose
of WNT3A (50% WNT3A CM, Figure 1—figure supplement 1B) and enriched for cells with the low-
est 10% reporter fluorescence (‘lowest 10%’ gate in Figure 1—figure supplement 1G) during two
sequential rounds of FACS sorting and amplification. Thirty-three genes were significantly enriched
for GT insertions in the sorted cells (Figure 1E and Supplementary file 1). These included genes
encoding several known positive regulators of the pathway, such as the WNT co-receptor LRP6,
components of the WNT transcription complex including CTNNB1, CREBBP and BCL9, and compo-
nents of a histone H3 K79 methyltransferase complex including DOT1L and MLLT10 (Figure 1A). As
expected, regulators with redundant expression profiles in HAP1 cells, such as FZDs or DVLs
(Table 1), were not recovered in this screen. Increasing the stringency of selection by sorting for cells
with the lowest 2% reporter fluorescence (‘lowest 2%’ gate in Figure 1—figure supplement 1H) did
not change the results of the screen significantly (Figure 1F and Supplementary file 1); despite dif-
ferences in the significance of GT insertion enrichment compared to the less stringent screen, the
order of the top hits was generally maintained. Considering the multiple experimental steps
involved, the results are remarkably reproducible. Henceforth, we refer to each of these two screens
for positive regulators as the ’low stringency’ (Figure 1E) and the ’high stringency’ (Figure 1F)
screen, respectively, and to both of them jointly as the ‘WNT screens’.
The second most significant hit in both WNT screens for positive regulators, following LRP6, was
TFAP4 (Figure 1E and F, and Supplementary file 1), a gene encoding a transcription factor not pre-
viously implicated in regulation of canonical WNT signaling. The fourth and third most significant hit
in the low (Figure 1E) and high (Figure 1F) stringency WNT screens, respectively, was AXIN2,
encoding the CTNNB1 destruction complex scaffold AXIN2. It was perplexing to find AXIN2 in a
screen for positive regulators, since components of the destruction complex are negative regulators
of the pathway, as illustrated by the presence of APC and CSNK1A1 in our initial screen (Figure 1C).
Experimental validation and analysis of both TFAP4 and AXIN2 follows in the two sections below.
These results establish that reporter-based, genome-wide forward genetic screens in haploid
human cells are an effective way to identify many non-redundant components of signaling pathways.
The versatility afforded by the combination of a reporter with a continuous fluorescence readout and
FACS as a means of enrichment enables identification of functionally distinct classes of genes includ-
ing negative, attenuating and positive regulators.
TFAP4 regulates WNT signaling downstream of the CTNNB1
destruction complex
The second most significant hit in both screens for positive regulators of WNT signaling (Figure 1E
and F, and Supplementary file 1), was the gene encoding the transcription factor TFAP4, outranked
only by the gene encoding the WNT co-receptor LRP6. TFAP4 is a helix-loop-helix leucine zipper
transcription factor and a target of MYC (Jung and Hermeking, 2009) that has been implicated in
epithelial-to-mesenchymal transformation and metastasis in CRC (Jackstadt et al., 2013; Shi et al.,
2014). Despite multiple reports correlating TFAP4 expression and malignancy in gastrointestinal
tumors (Cao et al., 2009; Liu et al., 2012; Xinghua et al., 2012), TFAP4 has not been previously
implicated as a regulator of canonical WNT signaling.
We used CRISPR/Cas9 to generate two HAP1-7TGP cell lines, designated TFAP4CR-1 and
TFAP4CR-2, the first of which lacks TFAP4 and the second of which produces a truncated protein
product that retains the leucine zipper motif (see Materials and methods, Figure 2C and
Supplementary file 2). We note that these and all the other cell lines generated using CRISPR/Cas9
and used in this work were isolated without any phenotypic selection and were genotyped by
sequencing the single allele of the disrupted gene (see Materials and methods and
Supplementary file 2). TFAP4CR-1 and TFAP4CR-2 cells showed a substantial reduction in WNT3A-
induced expression of endogenous AXIN2, a target gene commonly used as a metric for pathway
activity (Figure 2A). The defect in target gene induction correlated with the severity of the two
mutant alleles of TFAP4. WNT3A-induced reporter activation in TFAP4CR-1 cells could be rescued by
re-expression of TFAP4 (Figure 2B). TFAP4 overexpression in WT HAP1-7TGP cells increased
WNT3A-induced reporter signal by 2.6-fold but did not induce reporter activity in unstimulated cells
(Figure 2B), suggesting TFAP4 is a limiting factor for WNT signaling in these cells. The gain- and
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Figure 2. The transcription factor TFAP4 regulates WNT signaling downstream of the CTNNB1 destruction complex (A–D), and ectopic expression of
TFAP4, SERBP1 and HUWE1 in X. laevis embryos induces secondary body axis formation (E–F). (A) AXIN2 mRNA (average ± standard deviation (SD)
AXIN2 mRNA normalized to HPRT1 mRNA, each measured in triplicate reactions), relative to untreated WT cells, for single WT HAP1-7TGP and
TFAP4CR clonal cell lines (see Materials and methods and Supplementary file 2 for descriptions of all CRISPR/Cas9-engineered and GT-containing
clonal cell lines). Cells were treated with 50% WNT3A CM where indicated. (B) WNT reporter activity (median ± standard error of the median (SEM)
EGFP fluorescence from 1000 transfected cells), relative to untreated WT cells transfected with empty vector, for WT and TFAP4CR-1 cells transfected
with pCS2+ empty vector or pCSDest-TFAP4 (together with pmCherry as a co-transfection marker). Cells were treated with 50% WNT3A CM where
indicated. (C) Immunoblot analysis of WT and TFAP4CR clonal cell lines treated with 50% WNT3A CM where indicated. CTNNB1 protein levels
(CTNNB1 intensity normalized to GAPDH intensity), relative to untreated WT cells, are shown below the blots. Molecular weight standards (in
Figure 2 continued on next page
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loss-of-function effects of TFAP4 demonstrate an important regulatory role in WNT signaling in
human cells, consistent with its prominent position among the hits of the WNT screens—and indeed
of several other screens described later in this work.
Because it is a transcription factor, TFAP4 is likely to function downstream of the destruction com-
plex (Figure 1A). Depletion and truncation of TFAP4 in TFAP4CR-1 and TFAP4CR-2 cells, respectively,
did not affect WNT-dependent accumulation of CTNNB1 protein, a measure of destruction complex
activity (Figure 2C). We confirmed this conclusion by epistasis analysis, in which we activated signal-
ing in WT HAP1-7TGP and TFAP4CR-1 cells at various levels of the pathway by 1) addition of
WNT3A, which acts at the cell surface, 2) addition of the GSK3 inhibitor LiCl, which inactivates the
destruction complex, or 3) transfection with a non-degradable (ND), constitutively active CTNNB1
mutant (S33Y), which activates the transcription complex directly (Figure 2D). The response of
TFAP4CR-1 cells was reduced in all cases when compared to WT HAP1-7TGP cells. Thus, TFAP4 must
act together with or downstream of CTNNB1.
To test if TFAP4 can influence WNT signaling during development, we employed an established
body axis duplication assay in Xenopus laevis embryos. Activation of WNT signaling in the dorsal
side of the early X. laevis embryo is a critical event in the formation of the Spemann organizer,
an important tissue-organizing center found in vertebrates (Spemann, 1938), and ectopic activation
of WNT signaling in the ventral side leads to formation of a second body axis. Microinjection of
mRNA encoding TFAP4 into X. laevis embryos caused the formation of a secondary body axis
(Figure 2E and F), demonstrating that TFAP4 can promote ectopic activation of WNT signaling dur-
ing development.
Future work will focus on defining the contexts in which TFAP4 regulates WNT transcriptional
responses under physiological and pathological conditions, given that its site of action downstream
of the CTNNB1 destruction complex could be favorable for therapeutic intervention in cancers
where WNT signaling is activated by loss of APC or by mutations that stabilize CTNNB1.
The C-terminal DAX domain of AXIN2 controls CTNNB1 transcriptional
activity
AXIN genes encode the principal scaffold (reviewed in Tacchelly-Benites et al., 2013; Song et al.,
2014) and limiting component (Lee et al., 2003) of the CTNNB1 destruction complex. The two
paralogues in mammals, AXIN1 and AXIN2, are functionally redundant (Chia and Costantini, 2005),
although their expression patterns are quite distinct: AXIN1 is expressed ubiquitously, while AXIN2
is expressed at low levels in the absence of WNT signals (Jho et al., 2002). AXIN2 is also the key
component of a negative feedback loop in the WNT pathway (Lustig et al., 2002). As a universal
and direct target gene of the pathway, its increased expression following stimulation with WNT can
lead to elevated levels of the destruction complex and, consequently, reduced levels of CTNNB1.
Given this well-established negative regulatory role, the enrichment of GT insertions mapping to
AXIN2 in HAP1-7TGP cells with reduced WNT reporter activity recovered during the WNT screens
(Figure 1E and F, and Supplementary file 1) presented us with a paradox.
An important clue emerged from a careful inspection of the distribution of GT insertions mapping
to AXIN2 in the sorted cells. In most hits from haploid genetic screens, exemplified by LRP6
(Figure 3A), GT insertions cluster at the 5’ end of the gene because of the propensity of retroviral
integration near transcriptional start sites and because such insertions are likely to generate null
alleles (Carette et al., 2011a). Contrary to this general case, nearly all GT insertions in AXIN2
mapped to the opposite end of the gene in the last intron (Figure 3A). These insertions are
Figure 2 continued
kilodaltons (kDa)) are indicated on the left and the identity of the protein measured in each blot is indicated on the right. (D) WNT reporter activity
(median ± SEM EGFP fluorescence from 10,000 WNT3A- or LiCl-treated cells, or from 2800 cells transfected with non-degradable (ND, S33Y mutant)
CTNNB1) for WT and TFAP4CR-1 cells, depicted as percentage of WT. Cells were treated with 50% WNT3A CM or with 40 mM of the GSK3 inhibitor
LiCl, or they were transfected with ND CTNNB1 and pmCherry as a co-transfection marker. (E) Four-cell stage X. laevis embryos were injected ventrally
with 5 ng of mRNA encoding yellow fluorescent protein (YFP), X. laevis Wnt8, TFAP4, SERBP1 or HUWE1 and grown to stage 34. Dorsal (top panel of
each pair) and lateral (bottom panel of each pair) views for groups of three embryos are shown. Scale bar = 1 mm. (F) Percentage of embryos with a
secondary body axis. The total number of injected embryos is indicated below the group name.
DOI: 10.7554/eLife.21459.006
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Figure 3. The C-terminal DAX domain of AXIN2 controls CTNNB1 transcriptional activity. (A) GT insertions in LRP6 (top histogram) and AXIN2 (bottom
histogram) mapped for the sorted cells from the WNT positive regulator, low stringency screen (Figure 1E). The histograms depict the number of GT
integrations in the sense (blue) or antisense (red) orientation, relative to the coding sequence of the gene, within consecutive 500 base pair (bp)
intervals along the length of each gene. Due to the directionality of the splice acceptor in the GT, typically only sense GT insertions in introns disrupt
Figure 3 continued on next page
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predicted to produce a truncated AXIN2 protein product lacking exon 11 (Figure 3B), comprising
half of the DAX domain, which has been implicated both in CTNNB1 destruction complex function
and in interactions with the receptor complex at the plasma membrane (reviewed in Tacchelly-
Benites et al., 2013; Song et al., 2014).
The results of the WNT screens (Figure 1E and F, and Supplementary file 1) suggested that
deletion of half of the DAX domain of AXIN2 reduces responsiveness to WNT. The ease of genome
editing in haploid cells enabled us to precisely assess the magnitude of signaling defects by compar-
ing multiple independent WT and mutant HAP1-7TGP clonal cell lines containing specific mutations
in the single endogenous AXIN2 allele, which minimized the likelihood of non-specific effects and
accounted for interclonal variability. We used CRISPR/Cas9 to generate HAP1-7TGP cell lines lacking
exon 11 of AXIN2 (designated AXIN2DC, Figure 3B and Supplementary file 2). Since incomplete
protein domains can remain unfolded, we also generated multiple cell lines lacking the complete
DAX domain (AXIN2DDAX) and, as a control, cell lines lacking AXIN2 entirely (AXIN2KO) (Figure 3B
and Supplementary file 2). AXIN2KO clones exhibited no defect in WNT3A-dependent reporter
induction (Figure 3C) due to redundancy with AXIN1 (Figure 3—figure supplement 1A and B, and
Table 1). However, AXIN2DC and AXIN2DDAX clones exhibited, on average, a 65% and a 76% reduc-
tion in WNT3A-induced signaling, respectively, compared to WT HAP1-7TGP cells (Figure 3C). All
Figure 3 continued
the gene, whereas GT insertions in exons generally disrupt the gene regardless of orientation. RefSeq gene tracks for LRP6 and AXIN2 are shown
beneath each histogram following the University of California, Santa Cruz (UCSC) genome browser display conventions: coding exons are represented
by thick blocks, UTRs by thin blocks, and introns by horizontal lines connecting the blocks. Both genes are displayed with their 5’ ends to the left, and
encompass chromosome 12, bps 12267499–12116000 for LRP6, and chromosome 17, bps 65561999–65528500 for AXIN2 (hg18). (B) Schematic
representation of the human AXIN2 protein drawn to scale in the horizontal dimension. Amino acid numbers are indicated below, and arrows show the
sites at which truncations were made by CRISPR/Cas9-mediated genome editing in the indicated cell lines. Known domains, regions and motifs (based
on UniProt annotation) are depicted in gray (TB, tankyrase-binding motif). Exon 11, eliminated by GT insertions found in cells sorted during the WNT
screens for positive regulators, is delineated by a thinner white block. (C) Fold-induction in WNT reporter (median EGFP fluorescence from 20,000 cells)
following treatment with 50% WNT3A CM or 10 mM of the GSK3 inhibitor CHIR-99021. Each circle represents a unique clonal cell line (determined by
genotyping, Supplementary file 2), and the average of three to four independent clones for each genotype is indicated by a horizontal line. For each
treatment, percentage reporter activation relative to WT cells is also indicated above each group of circles to facilitate comparisons. Significance was
determined by one-way ANOVA, and is indicated as ****(p<0.0001) or ns (not significant). (D) Fold-induction in soluble CTNNB1 protein (average
CTNNB1 intensity normalized to ACTIN intensity from duplicate immunoblots) following treatment with 50% WNT3A CM or 10 mM CHIR-99021. Each
circle represents a unique clonal cell line, and the average of two independent clones for each genotype is indicated by a horizontal line. Significance
was determined by unpaired t-test with Welch’s correction. Representative immunoblots used for quantification of CTNNB1 and ACTIN are shown in
Figure 3—figure supplement 1C. (E) Nuclear CTNNB1 (average nuclear fluorescence per unit area from three fields of view) in single clonal cell lines
of the indicated genotypes was quantified as described in Materials and methods. Cells were treated with 50% WNT3A CM where indicated. For each
cell line, the fold-increase in CTNNB1 nuclear accumulation following treatment with WNT3A, expressed as percentage of WT, is also indicated above
the bars to facilitate comparisons. For WNT3A-treated cells, differences in nuclear CTNNB1 between WT and mutant cells were not statistically
significant as determined by one-way ANOVA. Examples of confocal sections used for quantification of nuclear CTNNB1 are shown in Figure 3—figure
supplement 2B–2D. (F) WNT reporter activity (median EGFP fluorescence from 10,000 cells), soluble CTNNB1 protein (average CTNNB1 intensity
normalized to ACTIN intensity from duplicate immunoblots), and nuclear CTNNB1 protein (average nuclear fluorescence per unit area from 2 to 3 fields
of view), depicted as percentage of WT, for cells treated with 50% WNT3A CM. Each circle represents a unique clonal cell line, and where applicable
the average of two independent clones is indicated by a horizontal line. (G) Adult D. melanogaster wings expressing Axin-V5 (top images) or AxinDC-V5
(bottom images) under the control of the c765-Gal4 driver. Loss of sensory bristles and tissue at the wing margin, indicative of impaired Wg signaling, is
shown (arrow) in the higher magnification view of the delineated area. While loss of Notch signaling can also result in wing margin defects due to a
requirement of Notch signaling for Wg expression at the dorso-ventral boundary in the wing imaginal disc (Diaz-Benjumea and Cohen, 1995), we
ruled out that possibility by confirming intact Wg expression in the wing imaginal disc of flies expressing AxinDC-V5 (Figure 3—figure supplement
3B). Scale bars = 20 mm. (H) Percentage of flies with wing margin defects. 4.3% of flies expressing Axin-V5 exhibited loss of bristles at the wing margin,
but no loss of wing tissue; 46.6% of flies expressing AxinDC-V5 exhibited loss of bristles at the wing margin as well as loss of wing tissue.
DOI: 10.7554/eLife.21459.007
The following figure supplements are available for figure 3:
Figure supplement 1. AXIN1 and AXIN2 are redundant in haploid human cells (A–B), and CTNNB1 protein is stabilized normally in AXIN2DC cells (C).
DOI: 10.7554/eLife.21459.008
Figure supplement 2. Cells lacking the C-terminal DAX domain of AXIN2 exhibit normal CTNNB1 nuclear accumulation following WNT treatment.
DOI: 10.7554/eLife.21459.009
Figure supplement 3. Expression of an Axin transgene encoding C-terminally truncated protein compromises Wg signaling in D. melanogaster.
DOI: 10.7554/eLife.21459.010
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AXIN2 mutant cell lines responded normally to the GSK3 inhibitor CHIR-99021 (Figure 3C), demon-
strating that the reduction in WNT3A-induced signaling was not due to defects in downstream steps
or to irrelevant factors affecting reporter fluorescence. The fact that C-terminally truncated AXIN2
reduced signaling induced by WNT3A explained why GT insertions generating this unusual AXIN2
allele were enriched in the WNT screens for positive regulators. Since HAP1-7TGP cells also express
AXIN1 (Figure 3—figure supplement 1A and Table 1), the effect of C-terminally truncated AXIN2
must be dominant.
We asked whether the reduction in WNT signaling caused by truncated AXIN2 was due to a
defect in WNT3A-induced CTNNB1 stabilization. Surprisingly, WNT3A robustly promoted the stabili-
zation of soluble CTNNB1 protein in AXIN2DC cells (Figure 3D and Figure 3—figure supplement
1C), revealing a disconnect between CTNNB1 protein abundance and transcriptional activity.
CTNNB1 accumulation in response to CHIR-99021 was also normal in AXIN2DC cells (Figure 3D, and
Figure 3—figure supplement 1C). The discrepancy between CTNNB1 stability and transcriptional
activity was not caused by defective nuclear accumulation; in both AXIN2DC and AXIN2DDAX cells,
accumulation of nuclear CTNNB1 following WNT treatment was largely normal (Figure 3E and Fig-
ure 3—figure supplement 2). We conclude from these experiments that deleting the DAX domain
of AXIN2 dissociates CTNNB1 protein abundance from its transcriptional activity.
These effects could reflect an autonomous property of the AXIN2 protein lacking the DAX
domain, or a more complex interaction with the remaining WT AXIN1. To rule out confounding
effects due to AXIN1, we disrupted the single allele of AXIN1 in individual AXIN2DC and AXIN2DDAX
clonal cell lines to generate double-mutant cell lines (AXIN1KO; AXIN2DC and AXIN1KO; AXIN2DDAX,
respectively, Supplementary file 2 and Figure 3—figure supplement 1A). The only AXIN protein
present in these cells is truncated AXIN2 lacking either half or the entire DAX domain. Truncated
AXIN2 caused the same effects upon elimination of AXIN1—decreased WNT3A-induced reporter
activity despite normal accumulation of soluble and nuclear CTNNB1 (Figure 3F and Figure 3—fig-
ure supplement 2). These findings provide further evidence that AXIN2 truncations disrupt
CTNNB1-mediated transcription through a novel mechanism intrinsic to this allele.
We tested the generality of our findings by introducing Axin transgenes into the fly Drosophila
melanogaster, a model organism that has been used extensively for genetic studies of WNT signal-
ing. We generated a transgene encoding an epitope-tagged (V5) fusion of the single D. mela-
nogaster Axin protein lacking the last 41 amino acids (AxinDC-V5, Figure 3—figure supplement
3A). These amino acids correspond to those encoded by exon 11 of human AXIN2, the exon dis-
rupted by GT insertions in the WNT screens (Figure 3A and B). Expression of AxinDC-V5 impaired
Wingless (Wg, fly WNT) signaling based on target gene expression and phenotypic readouts during
both embryonic and larval development (Figure 3G and H, and Figure 3—figure supplement 3B–
H). The observed defects in Wg signaling were not due to decreased expression of Wg itself (Fig-
ure 3—figure supplement 3B and C) or to increased expression of AxinDC-V5 protein (Figure 3—
figure supplement 3E and F). In control experiments, expression of WT Axin-V5 (Figure 3—figure
supplement 3A) at physiological levels (Wang et al., 2016) using the same promoter as for AxinDC-
V5 did not disrupt Wg signaling (Figure 3G and H, and Figure 3—figure supplement 3B–H). The
fact that in flies, like in haploid human cells, expression of an Axin transgene lacking the C-terminal
domain reduces Wg signaling even in the presence of endogenous Axin is consistent with a domi-
nant effect that restrains CTNNB1 transcriptional activity.
In summary, unbiased genome-wide screens for positive regulators of WNT signaling uncovered
an unsuspected role for the C-terminal DAX domain of AXIN2 in controlling CTNNB1 transcriptional
activity, since deletion of this domain led to a severely compromised transcriptional response
despite normal accumulation of CTNNB1 protein. While the mechanistic basis of this process
remains to be elucidated, our results cannot be explained by previously described functions of the
AXIN DAX domain. The DAX domain has been implicated in AXIN polymerization, in interactions
with DVL, and in mediating an intramolecular, auto-inhibitory interaction that allows the receptor
complex to inactivate the destruction complex in a catalytic manner (Fiedler et al., 2011; Kim et al.,
2013). These models predict that loss of the DAX domain would impair communication between the
receptor complex and the destruction complex, leading to defective WNT-induced CTNNB1 stabili-
zation, in contrast to our results (Figure 3D and F). Thus, the disconnect between CTNNB1 abun-
dance and transcriptional activity caused by deletion of the DAX domain demonstrates a new
biochemical function for this domain.
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The discovery of this dominant allele of AXIN2 was made possible by the untargeted nature of
GT-based insertional mutagenesis and thus would not have emerged from strict loss-of-function
screens such as those mediated by RNA interference or CRISPR/Cas9. Given that rare dominant
alleles can provide mechanistic insights distinct from those afforded by null alleles, our findings jus-
tify the design of comprehensive ‘exome-wide’ sgRNA libraries for CRISPR/Cas9-based screens.
A comparative analysis of screens uncovers requirements for RSPO-
potentiated signaling in response to low levels of WNT
RSPOs are stem cell growth factors that potentiate responses to WNT ligands by binding to LGR-
family receptors and neutralizing the ZNRF3 and RNF43 E3 ubiquitin ligases to increase levels of
WNT receptors on the cell surface (reviewed in de Lau et al., 2014; Figure 1A). Recurrent transloca-
tions in genes encoding RSPOs are found in some colorectal tumors and targeting the resulting
fusion proteins blocks tumorigenesis (Seshagiri et al., 2012; Storm et al., 2016). Mutations in
RNF43 that mimic the effect of stimulation with RSPO have also been reported in multiple cancers
(Giannakis et al., 2014). Regulators of RSPO-enhanced WNT signaling could therefore be important
both in normal physiological and in pathological contexts.
HAP1-7TGP cells were responsive to RSPO-mediated effects on WNT signaling. RSPO1 markedly
amplified the reporter response to low concentrations of WNT3A CM but was completely inactive in
the absence of WNT (Figure 4—figure supplement 1A). We determined the concentration of
WNT3A CM at which responsiveness to RSPO1 was maximal (Figure 4—figure supplement 1B) and
used these conditions in a sensitized genome-wide screen for mediators of RSPO-enhanced WNT
signaling. Notably, the concentration of WNT used in this screen, henceforth referred to as the ‘low
WNT + RSPO screen,’ was 49-fold lower than that used in the WNT screens for positive regulators
(Figure 1E and F).
Following treatment with WNT3A CM plus RSPO1, we isolated cells with the lowest 7% EGFP
fluorescence (‘lowest 7%’ gate in Figure 4—figure supplement 1C). After four consecutive sorts,
which resulted in a marked enrichment of cells with diminished responsiveness to WNT3A CM plus
RSPO1 (Figure 4—figure supplement 1C), we sequenced and mapped GT integrations (Figure 4A
and Supplementary file 1). Reassuringly, the top hit was LGR4, the gene encoding the RSPO1
receptor, confirming that the screen was sensitive to requirements for RSPO1-dependent signaling.
Top hits of this screen included many genes encoding known WNT regulators also uncovered in the
WNT screens for positive regulators (Figure 1E and F, and Supplementary file 1): LRP6, AXIN2,
DOT1L, MLL, CTNNB1, CREBBP, BCL9 and RNF146. TFAP4, encoding the required transcription
factor we described earlier in this study, was also among the top hits (Figure 4A and
Supplementary file 1).
We distinguished genes selectively required for RSPO-enhanced WNT signaling through a com-
parative analysis of the low WNT + RSPO screen (Figure 4A and Supplementary file 1) and both
WNT screens for positive regulators conducted at a near-saturating dose of WNT (Figure 1E and F,
and Supplementary file 1). For this analysis, we used two different measures of gene disruption
caused by GT integrations (see Materials and methods, Figure 4B and Supplementary file 3). First,
the FDR-corrected p-value, reflecting enrichment of GT integrations in the sorted vs. the unsorted
cells from each screen, was used to set a stringent cutoff for inclusion of hits in the analysis. Second,
an Intronic GT Insertion Orientation Bias (IGTIOB) score, reflecting enrichment of sense vs. antisense
GT integrations (relative to the coding sequence of the gene) in introns only for the sorted cells from
each screen, was used to compare hits between screens. The IGTIOB score relies on the fact that
generally only sense GT insertions in introns should inactivate genes due to the directionality of the
splice acceptor. Genes selectively required for RSPO-enhanced WNT signaling should show a pat-
tern of GT enrichment similar to that of the gene encoding the RSPO receptor, LGR4. Conversely,
regulators required for WNT signaling under all treatment conditions should be equally enriched for
GT integrations in all screens (Figure 4B and Supplementary file 3).
The most striking outcome of this analysis was the identification of multiple genes encoding com-
ponents of the GPI-anchor biosynthetic pathway that were enriched for GT insertions in the low
WNT + RSPO screen but not the WNT screens (Figure 4B and Supplementary file 3). Fourteen
genes in the GPI biosynthesis pathway had an FDR-corrected p-value<0.05 (Supplementary file 1
and Figure 4—figure supplement 1D). Therefore, a GPI-anchored protein may be particularly
important in mediating signaling triggered by a combination of RSPO and a low dose of WNT. The
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Figure 4. A comparative analysis of screens uncovers requirements for RSPO-potentiated signaling in response to low levels of WNT. (A) Circle plot
depicting genes enriched for GT insertions in the low WNT + RSPO screen for regulators of RSPO-enhanced WNT signaling. See legend to Figure 1C–
F for details. (B) Heat map comparing the two WNT positive regulator screens (Figure 1E and F) and the low WNT + RSPO screen (Figure 4A). Genes
enriched for GT insertions (FDR-corrected p-value<10 4) in at least one of the three screens were clustered based on their IGTIOB score in each screen
(see Materials and methods and Supplementary file 3). A group of genes preferentially enriched for GT insertions in the low WNT + RSPO screen is
Figure 4 continued on next page
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gene encoding the glypican GPC4, a GPI-linked heparan sulfate proteoglycan (HSPG), was
also preferentially enriched for GT insertions in the low WNT + RSPO screen (Figure 4B and
Supplementary file 3), with an FDR-corrected p-value=1.92x10 5, more significant than those of
established WNT signaling components such as CREBBP and BCL9 (Figure 4A and
Supplementary file 1). Glypicans are important for concentrating extracellular ligands at the cell sur-
face, and GPC4 has been proposed to bind and concentrate WNT3A and WNT5A in the vicinity of
their receptors (Sakane et al., 2012). However, since neither GPI biosynthesis nor glypican genes
were significant hits in the WNT screens for positive regulators (Figure 1E and F, and
Supplementary file 1), we hypothesized that these genes must play a crucial role under the condi-
tions of the low WNT + RSPO screen, either by mediating RSPO responsiveness like LGR4, or by
selectively affecting reception of WNT3A at the very low concentration used in this screen.
To distinguish between these two possibilities, we analyzed the signaling response to WNT3A
alone or to a low concentration of WNT3A plus RSPO1 in clonal HAP1-7TGP cell lines in which we
disrupted PIGL, a gene in the GPI biosynthesis pathway (Figure 4—figure supplement 1D), or
GPC4 (designated PIGLKO and GPC4KO, respectively, Supplementary file 2). The glypican GPC6 is
redundant with GPC4 in certain contexts (Allen et al., 2012), so we also generated HAP1-7TGP cell
lines in which we disrupted GPC6 alone or in combination with GPC4 (designated GPC6KO and
GPC4KO; GPC6KO, respectively, Supplementary file 2). As a control we generated a HAP1-7TGP
cell line lacking all three RSPO receptors (designated LGR4KO; LGR5KO; LGR6KO,
Supplementary file 2).
As expected from the role of LGRs as exclusive mediators of responsiveness to RSPO but not to
WNT, LGR4KO; LGR5KO; LGR6KO cells did not respond to RSPO1 in the presence of a low dose of
WNT3A, but exhibited no signaling defects when stimulated with higher doses of WNT3A alone
(Figure 4C and Figure 4—figure supplement 1E). In contrast, PIGLKO and GPC4KO; GPC6KO cells
manifested some reduction in signaling when stimulated with a near-saturating dose of WNT3A
alone, but this reduction was more pronounced following treatment with lower doses of WNT3A
alone or a low dose of WNT3A combined with RSPO1 (Figure 4C and Figure 4—figure supplement
1E). GPC4KO cells were stimulated normally by a near-saturating dose of WNT3A and exhibited a
smaller defect than GPC4KO; GPC6KO when stimulated with a lower dose of WNT3A alone or in
combination with RSPO1, while GPC6KO cells had no signaling defect at all (Figure 4C). These
results suggest that GPC4 and GPC6 are partially redundant in HAP1 cells, since they are both
expressed albeit at very different levels (Table 1). In a control experiment, WNT signaling induced
by the GSK3 inhibitor CHIR-99021 was largely unaffected in all mutant cell lines (Figure 4C), demon-
strating that there were no signaling defects downstream of the receptor complex (Figure 1A).
Taken together these results indicate that genes in the GPI biosynthesis pathway and GPC4/6 are
required for signaling in response to low levels of WNT, and explain why they may have been more
prominent hits in the low WNT + RSPO than in the WNT screens (Figures 1E,F and 4A and
Supplementary file 1). Presently, we cannot confirm or discount an additional, direct contribution of
GPC4/6 or another GPI-anchored protein to RSPO reception, as we have been unable to directly
measure responses to RSPO alone in HAP1 cells. Yet, the presence in all RSPOs of a thrombospon-
din domain capable of binding heparin sulfate and mediating interactions with HSPGs such as glypi-
cans (Nam et al., 2006; Ohkawara et al., 2011) makes this an intriguing possibility.
Figure 4 continued
indicated, headlined by the RSPO receptor LGR4. Genes selected for a detailed analysis are labeled in red. (C) Fold-induction in WNT reporter
(average EGFP fluorescence from 10,000 cells) following treatment with 50% WNT3A CM, 12.5% WNT3A CM, 1.43% WNT3A CM + 20 ng/ml RSPO1 or
10 mM of the GSK3 inhibitor CHIR-99021, expressed as percentage of the average for WT cells to facilitate comparisons. Each circle represents the fold-
induction for a unique clonal cell line (determined by genotyping, Supplementary file 2), and where applicable, the average of two to four
independent clones for each genotype is indicated by a horizontal line. Significance was determined by one-way ANOVA, and is indicated as ****
(p<0.0001), *(p<0.05) or ns (not significant).
DOI: 10.7554/eLife.21459.011
The following figure supplement is available for figure 4:
Figure supplement 1. Comparative genetic screens uncover requirements for RSPO-potentiated signaling in response to low levels of WNT.
DOI: 10.7554/eLife.21459.012
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In summary, our comparative analysis shows that forward genetic screens in haploid human cells
are exquisitely sensitive to both the identity and concentration of ligands used to initiate signaling.
They can uncover ligand-specific receptors, such as LGR4, or accessory factors that are rate-limiting
for signaling only under specific regimes of ligand concentrations, such as GPI biosynthetic enzymes
and glypicans. Of note, the low WNT + RSPO screen (Figure 4A and Supplementary file 1) was sen-
sitive enough to reveal redundant regulators, such as FZD5 and DVL3 (Table 1), that were not signifi-
cant hits under the near-saturating WNT3A dose used in the WNT screens (Figure 1E and F, and
Supplementary file 1).
Suppressor screens reveal genotype-specific signaling requirements
Given the potential of comparative screens to identify context-specific regulators, we searched for
genes whose inactivation would suppress the pathological signaling that ensues when key negative
regulators of the WNT pathway are lost. Since negative regulators such as APC are frequently
mutated in cancer, suppressor mutations and the mechanisms through which the affected genes reg-
ulate signaling may reveal therapeutic targets.
Our initial screen for rate-limiting negative regulators of WNT signaling (Figure 1C and
Supplementary file 1) suggested that disruption of the single allele of APC or CSNK1A1 in HAP1-
7TGP cells should lead to constitutive activation of the pathway. We designed two screens to
uncover suppressors of ligand-independent signaling induced by loss of APC or CSNK1A1
(Figure 5A). We disrupted APC or CSNK1A1 in HAP1-7TGP cells using CRISPR/Cas9 and isolated
two clonal cell lines designated APCKO-1 and CSNK1A1KO-1, respectively (Supplementary file 2).
Sequencing revealed frameshift mutations in the single allele of each gene. We confirmed by immu-
noblotting that the APC signal was reduced by >96.5% in APCKO-1 cells, and CSNK1A1 was unde-
tectable in CSNK1A1KO-1 cells (Figure 5—figure supplement 1A). The level of constitutive WNT
reporter fluorescence in both the APCKO-1 and CSNK1A1KO-1 clones was higher than that induced
by near-saturating WNT3A or by the GSK3 inhibitor CHIR-99021 in WT HAP1-7TGP cells (Figure 5—
figure supplement 1B).
In two independent screens, henceforth referred to as the ‘APC suppressor screen’ and the
‘CSNK1A1 suppressor screen,’ respectively, we mutagenized APCKO-1 and CSNK1A1KO-1 cells with
GT retrovirus and enriched for cells with the lowest 10% WNT reporter fluorescence (‘lowest 10%’
gate in Figure 5—figure supplement 1C and D). Following two sequential rounds of sorting and
amplification, 43% of APCKO-1 and 42% of CSNK1A1KO-1 cells were within this gate (Figure 5—fig-
ure supplement 1C and D). We analyzed the cells sorted during each screen and their respective
unsorted control populations for enrichment of GT insertions (Figure 5B and C, and
Supplementary file 1).
A three-way comparative analysis of the WNT positive regulator, low stingency screen in WT
HAP1-7TGP cells (Figure 1E), the APC suppressor screen and the CSNK1A1 suppressor screen (all
done at similar selection stringencies) revealed expected similarities and differences based on estab-
lished epistatic relationships, as well as a number of unexpected findings (Figure 5D and
Supplementary file 3). The isogenic background of the cells in these three screens and the very
high statistical significance of the top hits (only genes with an FDR-corrected p-value<10 4 in at least
one screen were included in this analysis) enabled us to make meaningful predictions, some of which
we confirmed experimentally.
Several groups of genes were clearly discernible based on their GT insertion enrichment patterns
across the three screens (Figure 5D and Supplementary file 3). As expected, genes encoding com-
ponents of the pathway that function downstream of the destruction complex, including CTNNB1
and CREBBP, were enriched for GT insertions in all three screens (Figure 5D and
Supplementary file 3). TFAP4 was also significantly enriched for GT insertions in all three screens
(Supplementary file 3), and it acts downstream of the destruction complex, as we confirmed experi-
mentally (Figure 2). However, TFAP4 had a low IGTIOB score in all screens (Figure 5D and
Supplementary file 3) because it represents a rare case of a gene that can be disrupted by both
sense and antisense GT insertions in an intron (Supplementary file 1), a finding that will be
described in detail elsewhere.
Also as expected, genes encoding components of the pathway upstream of the destruction com-
plex, such as LRP6, were predominantly enriched for GT insertions in the WNT, but not the APC or
CSNK1A1 suppressor screens (Figure 5D and Supplementary file 3). AXIN2 was also enriched for
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Figure 5. Suppressor screens in cells lacking APC or CSNK1A1 reveal genotype-specific signaling requirements. (A) Schematic of WNT reporter-based
suppressor screens. APC or CSNK1A1 was disrupted by CRISPR/Cas9-mediated genome editing of the WNT reporter haploid cell line HAP1-7TGP.
Individual clonal cell lines were isolated (APCKO-1 and CSNK1A1KO-1, Supplementary file 2) and mutagenized using GT retrovirus. Cells with reduced
reporter activity were enriched by FACS to identify suppressor mutations. (B–C) Circle plots depicting genes enriched for GT insertions in suppressor
Figure 5 continued on next page
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GT insertions in the WNT screen exclusively, suggesting that the mechanism responsible for reduc-
ing WNT responsiveness in cells containing AXIN2 truncations depends on other components of the
CTNNB1 destruction complex.
Hits enriched for GT insertions in both the APC and CSNK1A1 supprssor screens, but not the
WNT screen, likely represent a class of genes capable of modulating WNT signaling in the absence
of destruction complex activity. The most prominent hit in this category was SERBP1 (Figure 5D and
Supplementary file 3), encoding an RNA binding protein that has not been previously implicated in
WNT signaling. In the section that follows we explored how SERBP1 regulates WNT signaling in cells
lacking destruction complex activity.
Genes enriched for GT insertions predominantly in the APC suppressor screen included those
encoding various RNA binding proteins, components of the mRNA nonsense-mediated decay path-
way, and negative regulators of RNA polymerase (Figure 5D and Supplementary file 3), suggesting
a connection between RNA metabolism and signaling in APCKO-1 cells.
Surprisingly, there were a number of genes predominantly enriched for GT insertions in the
CSNK1A1 suppressor screen (Figure 5D and Supplementary file 3). Given that the principal role of
CSNK1A1 in WNT signaling is thought to be phosphorylation of CTNNB1 through the destruction
complex, it was not obvious why these same genes were not enriched for GT insertions in the APC
suppressor screen, where destruction complex activity was also disabled. The existence of this class
of genes, apparently required for WNT signaling only in cells lacking CSNK1A1, suggested a role for
CSNK1A1 in WNT signaling independent of the destruction complex. The most prominent gene in
this class encodes HUWE1, an E3 ubiquitin ligase that has been proposed to downregulate WNT sig-
naling by ubiquitinating DVL and preventing its multimerization (de Groot et al., 2014). In contrast,
the fact that mutations of HUWE1 caused a reduction in WNT reporter fluorescence during the
CSNK1A1 suppressor screen suggests a positive regulatory role. Below, we describe the peculiar
role of HUWE1 in mediating WNT signaling specifically in the context of CSNK1A1 loss.
APC is a prototypical human tumor suppressor gene frequently lost in both sporadic and familial
CRC. Importantly, reduction of WNT signaling through restoration of APC in a mouse model of CRC
can reverse tumorigenesis even in the presence of mutations in other potent cancer genes such as
TP53 and KRAS (Dow et al., 2015). Hence, genes selectively required to sustain the high-level WNT
signaling that ensues when APC or CSNK1A1 are lost, such as those suggested by our comparative
analysis, may represent potential therapeutic targets.
SERBP1 controls CTNNB1 abundance in cells lacking APC
The second top hit of the APC suppressor screen, after CTNNB1, was the gene encoding the mRNA
binding protein SERBP1 (Figure 5B and Supplementary file 1), also known as PAI-RBP1. SERBP1
was also a significant hit in the CSNK1A1 suppressor screen (Figure 5C and Supplementary file 1).
SERBP1 was initially identified as an mRNA binding protein that interacts with the cyclic nucleotide-
responsive sequence of the Type-1 plasminogen activator inhibitor mRNA and may play a role in
regulation of mRNA stability (Heaton et al., 2001). Yet, its cellular function remains largely unknown,
and it has never been implicated in regulation of WNT signaling.
To explore the consequences of disrupting SERBP1 in cells lacking APC we used an indepen-
dently isolated HAP1-7TGP clonal cell line with a lesion in the APC locus introduced by a GT inser-
tion (APCKO-2, see Materials and methods, Supplementary file 2 and Figure 6D). This ensured that
any effects on WNT signaling were not specific to the CRISPR/Cas9-induced lesion in the APCKO-1
Figure 5 continued
screens in which constitutive WNT signaling was induced by loss of APC (B) or CSNK1A1 (C). See legend to Figure 1C–1F for details. (D) Heat map
comparing the WNT positive regulator, low stringency screen (Figure 1E), and the APC and CSNK1A1 suppressor screens (Figure 5B and C). Genes
enriched for GT insertions (FDR-corrected p-value<10 4 ) in at least one of the three screens were clustered based on their IGTIOB score in each screen
(see Materials and methods and Supplementary file 3). Classes of genes preferentially enriched for GT insertions in various screens are indicated.
Genes selected for a detailed analysis are labeled in red.
DOI: 10.7554/eLife.21459.013
The following figure supplement is available for figure 5:
Figure supplement 1. Suppressor screens in cells lacking APC or CSNK1A1 reveal genotype-specific signaling requirements.
DOI: 10.7554/eLife.21459.014
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Figure 6. The mRNA binding protein SERBP1 controls CTNNB1 abundance in cells lacking APC (A–D), and the E3 ubiquitin ligase HUWE1 regulates
WNT signaling in the absence of CSNK1A1 (E–I). (A, E, I) WNT reporter activity (median EGFP fluorescence from 5000 (A), 20,000 (E) or 2000 (I) cells) for
the indicated single- and double-mutant cell lines. Each circle represents a unique clonal cell line and the average of 10 (A), 12 (E) or 19 (I)
independent clones for each genotype is indicated by a horizontal line. The average percentage reporter activity relative to single-mutant cell lines is
Figure 6 continued on next page
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cells used for the APC suppressor screen. As expected, APCKO-2 cells had constitutive WNT reporter
expression (Figure 5—figure supplement 1B). We used CRISPR/Cas9 to generate multiple indepen-
dent clonal cell lines derived from APCKO-2 cells that harbored additional inactivating mutations in
SERBP1, hereafter called APCKO-2; SERBP1KO cells (Supplementary file 2 and Figure 6D). Disrupt-
ing SERBP1 in cells lacking APC caused a substantial reduction in constitutive WNT reporter fluores-
cence, endogenous AXIN2 mRNA and soluble CTNNB1 protein abundance (Figure 6A–D, and
Figure 6—figure supplement 1A and B). Disrupting SERBP1 in WT HAP1-7TGP cells (SERBP1KO,
Supplementary file 2 and Figure 6D) did not affect basal or WNT3A-induced levels of AXIN2
mRNA or soluble CTNNB1 (Figure 6B–D, and Figure 6—figure supplement 1A and B), explaining
why SERBP1 was not enriched for GT insertions in the WNT screen for positive regulators of ligand-
induced signaling (Figure 5D and Supplementary file 3). Microinjection of SERBP1 mRNA into X.
laevis embryos resulted in duplication of the body axis, establishing SERBP1 as a bona fide positive
regulator of WNT signaling in vertebrates (Figure 2E and F).
In the absence of destruction complex activity, SERBP1 could conceivably reduce CTNNB1 abun-
dance by decreasing transcript or protein levels. No significant changes in CTNNB1 mRNA levels
were detected when SERBP1 was disrupted in either WT or mutant APC genetic backgrounds (Fig-
ure 6—figure supplement 1C), suggesting instead a reduction in CTNNB1 protein. Thus, SERBP1
can regulate CTNNB1 abundance in cells lacking APC. This mechanism, independent of destruction
complex activity, could be particularly well suited for therapeutic interference in tumors where APC
function is lost.
HUWE1 regulates WNT signaling in the absence of CSNK1A1
The third most significant hit of the CSNK1A1 suppressor screen, following CTNNB1 and CREBBP,
was HUWE1 (Figure 5C and Supplementary file 1). HUWE1 (also known as MULE, LASU1 and
UREB1) encodes a 480–482 kDa E3 ubiquitin ligase containing a C-terminal HECT domain with
diverse cellular functions (Bernassola et al., 2008). Previous work has implicated HUWE1 as a nega-
tive regulator of WNT signaling (de Groot et al., 2014). However, the results of our screens sug-
gested that in the absence of CSNK1A1, HUWE1 is a positive regulator of WNT signaling. To test
the role of HUWE1 in this context, we further engineered the CSNK1A1KO-1 cells used for the
CSNK1A1 suppressor screen, as well as an independently derived cell line with a different lesion in
CSNK1A1 (CSNK1A1KO-2, Supplementary file 2). In each parental cell line, we used two different
sgRNAs to disrupt HUWE1 and isolated multiple double-mutant clonal cell lines (designated
CSNK1A1KO-1; HUWE1KO and CSNK1A1KO-2; HUWE1KO, Supplementary file 2 and Figure 6H). Dis-
ruption of HUWE1 resulted in a consistent 82–90% reduction of constitutive WNT reporter fluores-
cence and an 80–85% reduction of endogenous AXIN2 mRNA (Figure 6E and F, and Figure 6—
figure supplement 1D and E). In addition, microinjection of HUWE1 mRNA into X. laevis embryos
resulted in duplication of the body axis at low frequency (Figure 2E and F), supporting a more gen-
eral role as a positive regulator.
In contrast to the 80–90% reduction in both WNT reporter fluorescence and target gene expres-
sion (Figure 6E and F, and Figure 6—figure supplement 1D and E), depleting HUWE1 in
Figure 6 continued
also indicated above each group of circles. Significance was determined by unpaired t-test with Welch’s correction and is indicated as ****(p<0.0001) or
ns (not significant). (B,F) AXIN2 mRNA (average ± SD of AXIN2 mRNA normalized to HPRT1 mRNA, each measured in triplicate reactions), relative to
untreated WT cells, for a single clonal cell line of each indicated genotype. Cells were treated with 50% WNT3A CM where indicated. The same cell
lines analyzed in B were also analyzed in C and D; the same cell lines analyzed in F were also analyzed in G and H. Analysis of additional independent
clonal cell lines is presented in Figure 6—figure supplement 1. (C,G) Soluble CTNNB1 protein (average ± SD of CTNNB1 intensity normalized to
GAPDH intensity from duplicate immunoblots), relative to untreated WT cells. Cells were treated with 50% WNT3A CM where indicated.(D,H)
Representative immunoblots of the indicated clonal cell lines. The CTNNB1 and corresponding GAPDH blots depicted in D and H were used for
quantification in C and G, respectively. Genotypes and treatments are indicated above the blots.
DOI: 10.7554/eLife.21459.015
The following figure supplement is available for figure 6:
Figure supplement 1. The mRNA binding protein SERBP1 controls CTNNB1 abundance in cells lacking APC (A–C), and the E3 ubiquitin ligase HUWE1
regulates WNT signaling in the absence of CSNK1A1 (D–G).
DOI: 10.7554/eLife.21459.016
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CSNK1A1KO-1; HUWE1KO cells reduced soluble CTNNB1 levels by only 20–32% (Figure 6G and H,
and Figure 6—figure supplement 1F). These results show that in cells lacking CSNK1A1, HUWE1
has a minor influence on CTNNB1 abundance, but that its predominant role in WNT signaling is dis-
tinct from the regulation of CTNNB1 protein levels.
Additionally, HUWE1 was not a significant hit in the WNT screens or the APC suppressor screen
(Figure 5D and Supplementary file 3), suggesting that its role is specific to cells lacking CSNK1A1.
Indeed, disruption of HUWE1 in WT HAP1-7TGP cells (HUWE1KO, Supplementary file 2 and
Figure 6H) did not cause significant changes in WNT3A-induced AXIN2 mRNA or CTNNB1 protein
abundance (Figure 6F–H, and Figure 6—figure supplement 1E and F). To directly test whether
HUWE1 disruption reduces WNT signaling in cells lacking CSNK1A1 but not other destruction com-
plex components, we disrupted HUWE1 in APCKO-1 cells (APCKO-1; HUWE1KO, Supplementary file
2), and found no measurable defect in WNT reporter florescence (Figure 6I). Signaling driven by
inhibition of GSK3 was also unaffected by the loss of HUWE1 in HUWE1KO cells (Figure 6—figure
supplement 1G).
In summary, the drastic defect in signaling caused by loss of HUWE1 in cells lacking CSNK1A1
and its ability to promote formation of a secondary body axis when expressed ectopically in X. laevis
embryos demonstrate a positive role for HUWE1 in WNT signaling. These effects are largely inde-
pendent of changes is CTNNB1 protein abundance and are not observed when other components
of the destruction complex are inactivated. From these results we conclude that CSNK1A1 regulates
WNT signaling by an additional mechanism distinct from its established role in CTNNB1 turnover,
and that this mechanism is mediated by HUWE1.
Discussion
A systematic genetic analysis in human cells revealed new regulatory features at most levels of the
WNT pathway, from signal reception to transcriptional activation (Figure 7). Based on a comparative
analysis of seven genome-wide screens, we confirmed known epistatic connections and assigned
new ones (Figure 7A). Even for some of the known WNT components, our analysis suggested unex-
pected regulatory mechanisms.
First, as predicted by their enrichment in the WNT screens for positive regulators (Figure 7A),
atypical GT insertions in AXIN2 caused an unexpected decrease in WNT signaling (Figure 3). These
results are explained by the observation that in cells lacking the DAX domain of AXIN2, CTNNB1 is
appropriately stabilized and localized to the nucleus following WNT stimulation, but remains inactive
(Figure 3). Second, genes encoding components of the GPI anchor biosynthetic machinery, such as
PIGL, and the glypican GPC4 were predominantly enriched for GT insertions in the low WNT +
RSPO screen (Figure 7A), and we demonstrated that they indeed play a critical role in mediating
signaling especially under the low WNT conditions in which RSPOs exert their strongest effect (Fig-
ure 4). Third, the enrichment of GT insertions in HUWE1 only in the CSNK1A1 suppressor screen
(Figure 7A) revealed a unique signaling condition created by disruption of CSNK1A1, but not other
destruction complex components such as APC or GSK3. Only in this very specific context WNT sig-
naling was dependent on HUWE1 (Figure 6). This positive regulatory function of HUWE1 is evidently
different from the negative feedback regulation described previously (de Groot et al., 2014).
The presence of mutations in known regulators in the expected screens demonstrates the predic-
tive power of our approach, which enabled us to infer the site of action of newly identified pathway
components. The transcription factor TFAP4 would be predicted to act downstream of the CTNNB1
destruction complex based on its disruption in all screens for positive regulators of signaling
(Figure 7A), as our experimental results confirmed (Figure 2). The selective disruption of SERBP1 in
only the APC and CSNK1A1 suppressor screens (Figure 7A) suggests a regulatory role on signaling
independent of destruction complex activity, which we demonstrated experimentally (Figure 6).
An important conclusion from our studies is that WNT signaling can be regulated by processes
other than control of CTNNB1 protein abundance by the destruction complex. We demonstrate two
distinct instances in which CTNNB1 transcriptional activity can be dissociated from protein levels,
one caused by truncation of the AXIN2 DAX domain and the other caused by depletion of HUWE1
in cells lacking CSNK1A1. It will be interesting to explore if these phenomena can be exploited for
therapeutic purposes in tumors driven by inappropriate stabilization of CTNNB1. We also provide
evidence that the destruction complex does not have a unitary function in controlling CTNNB1
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protein abundance, since disrupting distinct components produces different outcomes.
Supressor screens in cells lacking APC or CSNK1A1 revealed mutations in substantially different sets
of genes (Figure 5), and while SERBP1 controls CTNNB1 abundance in cells lacking APC, the effects
of HUWE1 in cells lacking CSNK1A1 are largely independent of changes in CTNNB1 levels
(Figure 6).
From these studies a more elaborate picture of the core WNT signaling cascade emerges, with
additional regulation superimposed on the core module (Figure 7B). Further studies will be required
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Figure 7. A comparative analysis of seven genome-wide screens revealed epistatic connections and regulatory mechanisms in WNT signaling. (A)
Summary of known regulators, and new regulators or regulators mediating new mechanisms in WNT signaling validated in this study. An ‘X’ denotes
that the gene was enriched for GT insertions in the sorted cells from the indicated genetic screen (FDR-corrected p-value<0.05). Known regulators are
grouped into functional modules and arranged according to previously described epistatic relationships. Epistatic relationships for new regulators or
regulators mediating new mechanisms are inferred based on their patterns across screens. The screens in which cells were sorted for increased WNT
reporter fluorescence are labeled in red, and those in which cells were sorted for reduced WNT reporter fluorescence are labeled in green. For the
‘WNT positive regulator’ column, hits from the WNT screens done at both low and high stringency (Figure 1E and F) were considered together. For
AXIN2, the asterisk indicates that GT insertions mapped in the sorted cells generate a dominant allele that encodes a truncated protein product. (B)
Model of WNT/CTNNB1 signaling, highlighting in red new regulatory mechanisms uncovered and validated in this study. Red arrows represent genetic
(rather than biochemical) interactions. The various proposed mechanisms are discussed throughout the Results and Discussion sections.
DOI: 10.7554/eLife.21459.017
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physiological or pathological contexts in which they act. Yet, the comparative analysis of seven unbi-
ased genome-wide screens and the characterization of hits through a quantitative assessment of
CRISPR/Cas9-engineered clonal cell lines provided many insights into this complex developmental
signaling pathway. The conceptual and methodological framework described in this work should
enable the comprehensive understanding of other signaling systems.
Materials and methods
Reagent providers
Reagents were obtained from the following companies: Thermo Fisher Scientific, Waltham, MA;
Sigma-Aldrich, St. Louis, MO; Bio-Rad, Hercules, CA; Cell Biolabs, San Diego, CA; Clontech, Moun-
tain View, CA; Promega, Madison, WI; GE Healthcare Life Sciences, Logan, UT; GE Dharmacon,
Lafayette, CO; Addgene, Cambridge, MA; BD Biosciences, San Jose, CA; Abcam, Cambridge, MA;
EMD Millipore, Billerica, MA; Bethyl Laboratories, Montgomery, TX; Santa Cruz Biotechnology, Dal-
las, TX; R and D Systems, Minneapolis, MN; Cell Signaling Technology, Danvers, MA; Li-Cor, Lincoln,
NE; Jackson ImmunoResearch Laboratories, West Grove, PA; Developmental Studies Hybridoma
Bank at the University of Iowa (DSHB), Iowa City, IA; American Type Culture Collection (ATCC), Man-
assas, VA; Atlanta Biologicals, Flowery Branch, GA; Pall Corporation, Fribourg, Switzerland;
Selleckchem, Houston, TX; Roche, Mannheim, Germany; QIAGEN Sciences, Hilden, Germany; New
England Biolabs (NEB), Ipswich, MA; Epicentre, Madison, WI; Corning, Corning, NY; Bloomington
Drosophila Stock Center at Indiana University (BDSC), Bloomington, IN.
Plasmids
7TGP was a gift from Roel Nusse (Addgene plasmid # 24305). pX330-U6-Chimeric_BB-CBh-hSpCas9
(pX330) was a gift from Feng Zhang (Addgene plasmid # 42230). pCSDest was a gift from Nathan
Lawson (Addgene plasmid # 22423). pCS2+, pCS2-YFP, pCS2-b-cat-S33Y, pCS2-xWnt8, VSV-G and
D8.9 were a gift from Henry Ho.
The following plasmids were purchased: pAdVAntage (Promega Cat. # E1711), pCMV-VSV-G
(Cell Biolabs Cat. # RV-110), pCMV-Gag-Pol (Cell Biolabs Cat. # RV-111), pENTR-D-TOPO (Thermo
Fisher Scientific Cat. # K240020), pENTR2B (Thermo Fisher Scientific Cat. # A10463).
To generate pCSDest-TFAP4, human TFAP4 was amplified by PCR from MGC Human Sequence-
verified cDNA (Clone ID 4181538, GE Dharmacon Cat. # MHS6278-202757542) using primers
hTFAP4-FOR (5’-CACCATGGAGTATTTCATGGTGCCCA-3’) and hTFAP4-REV (5’- TCAGGGAAGC
TCCCCGT-3’), designed to add a directional TOPO cloning sequence at the 5’ end. The resulting
PCR product was cloned directionally into pENTR-D-TOPO. Individual clones were screened by
digestion with NotI and PstI for the presence of the insert in the correct orientation, and one clone
was sequenced completely and subcloned into pCSDest using the Gateway LR Clonase II Enzyme
mix (Thermo Fisher Scientific Cat. # 11791100).
To generate pCSDest-1D4-SERBP1, human SERBP1 was amplified by PCR from MGC Human
Sequence-verified cDNA (Clone ID 4477452, GE Dharmacon Cat. # MHS6278-202758125) using pri-
mers FNNterminal (5’-TTTTGAATTCGCCACCATGACCGAGACCAGCCAGGTGGCCCC
TGCAGGCGGCCGGCCACCTGGGCACTTACAGGAAGG-3’), designed to add an N-terminal Kozak
sequence, a 1D4 tag and a single glycine linker flanked by EcoR1 and FseI restriction sites, and
RNNterminal (5’-TTTTCTCGAGGGCGCGCCTTAAGCCAGAGCTGGGAATG-3’), designed to add
tandem AscI and XhoI restriction sites after the stop codon. The product was digested with EcoRI
and XhoI, and subcloned into pENTR2B digested at the same sites. One clone was sequenced
completely and subcloned into pCSDest using the Gateway LR Clonase II Enzyme mix.
To generate pCSDest-HUWE1, codon optimized HUWE1 in pDONR221, a gift from Sarah J.
Luchansky (Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research,
Cambridge, MA), was subcloned into pCSDest using the Gateway LR Clonase II Enzyme mix.
pCherry-C1 was created by replacing DsRed with mCherry RFP (Shaner et al., 2004) in pDsRed-
monomer-C1 (Clontech Cat. # 632466). An mCherry RFP PCR fragment was obtained using primers
5’-GATCGCTAGCACCATGGTGAGCAAGGGCGAGGAGGATAAC-3’ and 5’-GATCCTCGAGATCTC
TTGTACAGCTCGTCCATGCCGCC-3’. The PCR product was digested with NheI and XhoI and
ligated into pDsRed-monomer-C1 digested with the same enzymes.
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pGT-mCherry and pGT+1mCherry retroviral gene trap (GT) vectors (diagrammed schematically in
Figure 1B), containing an inactivated 3’LTR, a strong adenoviral (Ad40) splice acceptor site, mCherry
RFP in two different reading frames following the splice acceptor site, and the SV40 polyadenylation
signal, were created by replacing GFP with mCherry RFP in pGT-GFP (Carette et al., 2009). To cre-
ate pGT-mCherry, the following primers were used to generate a PCR product containing the splice
acceptor site followed by mCherry: 5’-GATCATCGATGCGCAGGCGCAATCTTCGCATTTC
TTTTTTCCAGATGGTGAGCAAGGGCGAGG-3’ and 5’-GATCGGATCCTTACTTGTACAGCTCGTCCA
TG-3’. To create pGT+1mCherry, the following primers were used: 5’-GATCATCGATGCGCAGGCG-
CAATCTTCGCATTTCTTTTTTCCAGGATGGTGAGCAAGGGCGAGG-3’ and 5’-GATCGGATCCTTAC
TTGTACAGCTCGTCCATG-3’. The PCR products were digested with ClaI and BamHI and cloned
into pGT-GFP digested with the same enzymes.
All constructs were confirmed by sequencing.
Antibodies
For immunoblotting
Primary antibodies: mouse anti-b-catenin (Clone 14/Beta-Catenin) (1:1000, BD Biosciences Cat. #
610154), mouse anti-GAPDH [6 C5] (1:5000, Abcam Cat. # ab8245), mouse anti-ACTIN (clone C4)
(1:500, EMD Millipore Cat. # MAB1501), rabbit anti-AP4 (TFAP4) serum (1:2000, a gift from Takeshi
Egawa; Egawa and Littman, 2011), rabbit anti-SERBP1 (1:5000, Bethyl Laboratories Cat. # A303-
938A), goat anti-casein kinase Ia (C-19) (1:200, Santa Cruz Biotechnology Cat. # sc-6477), rabbit
anti-APC (C-20) (1:500, Santa Cruz Biotechnology Cat. # sc-896), rabbit anti-Lasu1/Ureb1 (HUWE1)
(Bethyl Laboratories Cat. # A300-486A), goat anti-AXIN1 (1:1250, R and D Systems Cat. # AF3287),
rabbit anti-AXIN2 (76 G6) (1:500, Cell Signaling Technology Cat. # 2151), mouse anti-V5 (1:5000,
Thermo Fisher Scientific Cat. # R960CUS (formerly 46–1157)), mouse anti-a-Tubulin (clone DM1A)
(1:10,000, Sigma-Aldrich Cat. # T6199).
Secondary antibodies: IRDye 800CW donkey anti-mouse IgG (H+L) (1:10,000, Li-Cor Cat. # 926–
32212), IRDye 680RD donkey anti-rabbit IgG (H+L) (1:10,000, Li-Cor Cat. # 925–68073), peroxidase
AffiniPure donkey anti-goat IgG (H+L) (1:5000, Jackson ImmunoResearch Laboratories Cat. # 705-
035-003), peroxidase AffiniPure goat anti-rabbit IgG (H+L) (1:7500, Jackson ImmunoResearch Labo-
ratories Cat. # 111-035-003), peroxidase AffiniPure donkey anti-mouse IgG (H+L) (1:5000, Jackson
ImmunoResearch Laboratories Cat. # 715-035-150), goat anti-mouse IgG (H+L) HRP conjugate
(1:10,000, Bio-Rad Cat. # 1706516).
Primary and secondary antibodies used for detection with the Li-Cor Odyssey imaging system
were diluted in a 1 to 1 mixture of Odyssey Blocking Buffer (Li-Cor Cat. # 927–40000) and TBST (Tris
buffered saline (TBS) + 0.1% Tween-20), and those used for detection by chemiluminescence were
diluted in TBST + 5% skim milk. All primary antibody incubations were done overnight at 4˚C, and
secondary antibody incubations were done for 1 hr at room temperature (RT).
For immunostaining
Primary antibodies: mouse anti-b-catenin (Clone 14/Beta-Catenin) (1:500, BD Biosciences Cat. #
610154), mouse anti-Wingless (1:25, DSHB Cat. # 4D4 (supernatant) for D. melanogaster wing imagi-
nal discs and 1:200, DSHB Cat. # 4D4 (concentrate) for embryos), guinea pig anti-Senseless
(1:1000; Nolo et al., 2000), mouse anti-Engrailed/Invected (1:100, DSHB Cat. # 4D9 (concentrate)).
Secondary antibodies: donkey anti-mouse IgG (H+L) Alexa Fluor 647 conjugate (1:250, Thermo
Fisher Scientific Cat. # A-31571), donkey anti-mouse IgG (H+L) Alexa Fluor 555 conjugate (1:400,
Thermo Fisher Scientific Cat. # A-31570), goat anti-guinea pig IgG (H+L) highly cross-adsorbed,
Alexa Fluor 488 conjugate (1:400, Thermo Fisher Scientific Cat. # A-11073).
Cell lines and growth conditions
L Wnt-3A (ATCC Cat. # CRL-2647), L cells (ATCC Cat. # CRL-2648), 293T (ATCC Cat. # CRL-3216)
and 293FT cells (Thermo Fisher Scientific Cat. # R70007) were grown at 37˚C and 5% CO2 in com-
plete growth medium (CGM) 1: Dulbecco’s Modified Eagles Medium (DMEM) with High Glucose,
without L-Glutamine and Sodium Pyruvate (GE Healthcare Life Sicences Cat. # SH30081.01); 1X Glu-
taMAX-I (Thermo Fisher Scientific Cat. # 35050079); 1X MEM Non-Essential Amino Acids (Thermo
Fisher Scientific Cat. # 11140050); 1 mM Sodium Pyruvate (Thermo Fisher Scientific Cat. #
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11360070); 40 Units/ml Penicillin, 40 mg/ml Streptomycin (Thermo Fisher Scientific Cat. # 15140122);
10% Fetal Bovine Serum (FBS) (Atlanta Biologicals Cat. # S11150). HAP1 haploid human cells (kindly
provided by Thijn Brummelkamp, now available from Horizon Discovery, Cambridge, United King-
dom) were derived and characterized as described previously (Carette et al., 2011b). Throughout
the course of experiments, the ploidy of HAP1 cells and derivatives thereof was routinely tested by
DNA content analysis of propidium iodide (PI)-stained nuclei, as described below. Genetically modi-
fied clonal derivatives were confirmed by sequencing of target loci and in some cases immunoblot-
ting, as described below (see also Supplementary file 2). HAP1 cells and derivatives thereof were
grown at 37˚C and 5% CO2 in CGM 2: Iscove’s Modified Dulbecco’s Medium (IMDM) with L-gluta-
mine, with HEPES, without Alpha-Thioglycerol (GE Healthcare Life Sciences Cat. # SH30228.01); 1X
GlutaMAX-I; 40 Units/ml Penicillin, 40 mg/ml Streptomycin; 10% FBS.
Preparation of WNT3A and L cell conditioned media
L Wnt-3A cells or L cells were seeded in 15 cm tissue culture-treated dishes at a density of 1.5  106
cells per dish and grown in 25 ml of CGM 1. After 3 days, the medium was refreshed, and after an
additional 3 days, WNT3A or L cell conditioned medium (used as a control) was collected, filtered
through a 0.2 mm polyethersulfone (PES) membrane filter, aliquoted, flash-frozen in liquid nitrogen
and stored at  80˚C. The medium was thawed immediately before use, and leftover medium was
used only after one additional freeze-thaw cycle.
Construction of HAP1-7TGP WNT reporter haploid cell line
Lentivirus containing the 7TGP WNT reporter construct (Fuerer and Nusse 2010) was produced in
293T cells. ~24 hr before transfection, 293T cells were seeded in a 10 cm dish at a density of 4  106
per dish and grown in 10 ml of CGM 1. When the cells were nearly confluent, the medium was
replaced with CGM 1 without antibiotics. To prepare a calcium phosphate transfection mix, 8 mg of
7TGP plasmid, 4 mg of VSV-G, 4 mg of D8.9 and 0.5 mg of pCS2-YFP (used as a co-transfection
marker) in 450 ml of sterile water were mixed with 50 ml of 2.5 M CaCl2. The DNA/CaCl2 solution was
added to 500 ml of 2X HBS (42 mM HEPES pH 7.04, 274 mM NaCl, 10 mM KCl, 15 mM dextrose, 1.4
mM Na2HPO4.7H2O) and mixed by bubbling air through the solution. Following a 20 min incubation
at RT, the transfection mix was added drop-wise to the dish of cells and mixed by gentle agitation.
The medium was refreshed 16 hr post-transfection, at which time the efficiency of transfection was
assessed by microscopic inspection of YFP fluorescence. Lentivirus-containing medium was collected
36, 48 and 60 hr post-transfection (30 ml total), filtered through 0.45 mm filters (Acrodisc syringe fil-
ters with Supor membrane, Pall Corporation) and concentrated by ultracentrifugation for 1.5 hr at
23,000 rpm in a Sorvall Surespin 630 rotor. The supernatants were discarded, and the pellets over-
laid by a total of 200 ml of sterile phosphate buffered saline (PBS) supplemented with 1 mg/ml
bovine serum albumin (BSA). Following 12 hr of incubation at 4˚C, the pellets were resuspended, ali-
quoted, flash-frozen in liquid nitrogen, and stored at  80˚.
Approximately 48 hr before transduction, HAP1 cells were seeded in 10 cm dishes at a density of
1.5  106 per dish and grown in 10 ml of CGM 2. Cells were transduced with 145 ml of freshly
thawed lentivirus diluted in 10 ml of CGM 2 supplemented with 4 mg/ml polybrene. ~48 hr post-
transduction cells were treated with 1 mg/ml puromycin to select for those with a stably integrated
7TGP cassette. After selection was complete (assessed by death of >99% of control, untransduced
HAP1 cells), surviving cells were treated for 16–24 hr with 50% WNT3A CM in CGM 2, and single
WNT3A-responsive cells exhibiting the highest ~50% EGFP fluorescence were sorted by FACS into
96-well plates containing 200 ml of CGM 2 per well. After 14 days of undisturbed growth, individual
clones were amplified and haploid HAP1-7TGP clonal cell lines were identified by DNA content anal-
ysis of PI-stained nuclei (Nicoletti et al., 1991): 1.5  106 cells were incubated with 300 ml of hypo-
tonic fluorochrome solution (50 mg/ml PI, 0.1% sodium citrate, 0.1% Triton X-100) for >15 min at RT
and PI fluorescence was measured by FACS in a BD LSRFortessa cell analyzer (BD Biosciences) using
a 561 laser and 600 LP, 610/20 BP filters. A haploid cell line with low basal reporter activity and a
high dynamic range of EGFP fluorescence in response to WNT3A (Figure 1—figure supplement
1A) was expanded and used in all subsequent studies.
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Analysis of WNT reporter fluorescence
To measure WNT reporter activity in HAP1-7TGP cells or derivatives thereof, ~24 hr before treat-
ment cells were seeded in 24-well plates at a density of 8  104 per well and grown in 0.5 ml of
CGM 2. Cells were treated for 16–24 hr with the indicated concentrations of WNT3A CM, L cell CM,
recombinant mouse WNT3A (R and D Systems Cat. # 1324-WN) recombinant human RSPO1 (R and
D Systems Cat. # 4645-RS), LiCl, CHIR-99021 (CT99021) (Selleckchem Cat. # S2924) or XAV-939 (Sell-
eckchem Cat. # S1180) diluted in CGM 2. Cells were washed with 0.5 ml PBS, harvested in 150 ml of
0.05% Trypsin-EDTA (0.05%) (Thermo Fisher Scientific Cat. # 25300054), resuspended in 450 ml of
CGM 2, and EGFP fluorescence was measured immediately by FACS on a BD LSRFortessa cell ana-
lyzer (BD Biosciences) using a 488 laser and 505 LP, 530/30 BP filters, or on a BD Accuri RUO Special
Order System (BD Biosciences). Typically, fluorescence data for 5000–20,000 singlet-gated cells was
collected and, unless indicated otherwise, the median EGFP fluorescence ± standard error of the
median (SEM = 1.253 s/Hn, where s = standard deviation and n = sample size) was used to repre-
sent the data.
Reporter-based forward genetic screens
Mutagenesis of haploid cells with GT retrovirus
HAP1-7TGP cells or derivatives thereof were mutagenized as described previously (Carette et al.,
2011a), with some modifications. GT-containing retrovirus was produced in 293FT cells. ~24 hr
before transfection, a total of 9  107 cells were seeded in 6 T-175 flasks (1.5  107 per flask), each
containing 30 ml of CGM 1 without antibiotics. The medium in each T-175 flask was refreshed imme-
diately before transfection, and cells were transfected with a transfection mix prepared as follows:
3.3 mg each of pGT-mCherry and pGT+1mCherry, 1.7 mg pAdVAntage, 2.6 mg pCMV-VSV-G and 4
mg pCMV-Gag-Pol were prepared in 450 ml serum-free DMEM (GE Healthcare Life Sicences Cat. #
SH30081.01), and 45 ml of the X-tremeGENE HP DNA transfection reagent (Roche Cat. #
06366546001) were added and incubated for 20 min at RT. The medium was refreshed ~24 hr post-
transfection, and retrovirus-containing supernatant was collected ~48 and ~56 hr post-transfection.
The virus-containing supernatant was immediately filtered through 0.45 mm filters and concentrated
by ultracentrifugation for 1.5 hr at 23,000 rpm in a Beckman SW 32 Ti or a Sorvall Surespin 630 rotor.
Most of the supernatant was removed, leaving behind a small volume to cover the pellet. The virus
was incubated at 4˚C for ~12 hr, resuspended in CGM 2, pooled and supplemented with 4 mg/ml
polybrene.
Approximately 1.2  108 HAP1-7TGP, APCKO-1 or CSNK1A1KO-1 cells were mutagenized by trans-
duction with retroviral supernatant. ~24 hr before transduction, 6  107 cells sere seeded in 3 T-175
flasks (2  107 per flask), each containing 30 ml of CGM 2. All the freshly prepared retrovirus was
divided into three equal parts, and added to each of the three flasks of cells in two doses ~8 hr
apart. Cells were amplified by passaging every ~48 hr, and during each passage cells from all flasks
were pooled and 1.2  108 were re-seeded in order to retain the complexity of the mutagenized
library. 3  107 mutagenized cells were used to generate a control dataset of GT insertions (see
below).
FACS-based phenotypic enrichment
Screens were started at least 6 days following mutagenesis; for some screens, mutagenized cells
were frozen 3 days following transduction with GT-containing retrovirus, and allowed to recover for
at least 3 days after thawing and before starting treatments for the screens. ~24 hr before treatment,
a total of 1.25  108 cells were seeded in 5 T-175 flasks (2.5  107 per flask), and grown in 30 ml of
CGM 2. Cells were treated for 16–24 hr as follows: for the WNT negative regulator screen
(Figure 1C), and for the APC (Figure 5B) and CSNK1A1 (Figure 5C) suppressor screens, cells were
left untreated; for the WNT attenuating regulator screen (Figure 1D) cells were treated with 12.5%
WNT3A CM; for the WNT positive regulators screens at low (Figure 1E) and high (Figure 1F) strin-
gencies, cells were treated with 50% WNT3A CM; for the low WNT + RSPO screen (Figure 4A), cells
were treated with 1.04% WNT3A CM and 10 ng/ml recombinant human RSPO1. Cells were har-
vested, concentrated to ~2107 per ml, strained through a 70 mm cell strainer and a minimum of 2.5
 107 singlet-gated cells from each flask were sorted in a BD FACSAria Special Order Research
Product (BD Biosciences) cell sorter through a 70 mm nozzle, using gates encompassing the
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indicated levels of WNT reporter (EGFP) fluorescence. In this way, a total of 1.25  108 cells from
five flasks were sorted, retaining the diversity of the initial mutant library. A population of singlet-
gated cells (not gated based on WNT reporter fluorescence) was also sorted and carried along as a
control to set FACS gates during subsequent sorts.
Cells were expanded for 6–8 days to allow recovery and resetting of the WNT reporter, and a
portion of the cells (three to four times the number of cells enriched for during the prior sort, in
order to maintain an over-representation of the library diversity) was used in the subsequent round
of sorting, following the same treatments and FACS gating criteria described above for each screen.
For the WNT negative (Figure 1C), attenuating (Figure 1D), and positive regulator screens at low
(Figure 1E) and high (Figure 1F) stringencies, as well as for the APC (Figure 5B) and CSNK1A1
(Figure 5C) suppressor screens, cells underwent a total of two consecutive rounds of FACS sorting.
For the low WNT + RSPO screen (Figure 4A), cells underwent a total of four consecutive rounds of
FACS sorting. 3  107 cells expanded following the final sort for each screen were used to generate
a dataset of GT insertions in the sorted cell populations (see below).
Preparation of genomic GT insertion libraries for deep sequencing
To map GT insertions in control and sorted cells, sequencing libraries were prepared using a linear
amplification (LAM) PCR-mediated method described previously (Carette et al., 2011a), with modi-
fications. Steps prior to and following each of the two PCR amplifications were carried out in sepa-
rate dedicated lab spaces to avoid cross-contamination. Genomic DNA was extracted using the
QIAamp DNA Mini Kit (QIAGEN Cat. # 51304) according to the manufacturer’s ‘Spin Protocol: DNA
Purification from Blood or Body Fluids’. Each 3  107 cell pellet was resuspended in 600 ml PBS, split
into three columns, and eluted in 100 ml ultrapure water per column. Typically, 100–130 mg of total
genomic DNA were recovered.
A total of 40 mg of DNA were used for the subsequent step, in which 20 mg of DNA were sepa-
rately digested with 100 units of MseI (NEB Cat. # R0525L) or SpeI (NEB Cat. # R0133L) in a 100 ml
reaction containing 1X CutSmart buffer, with overnight incubation at 37˚C. DNA from each digest
was purified with the QIAquick PCR Purification Kit (QIAGEN Cat. # 28104) according to the manu-
facturer’s protocol, using two separate columns and eluting from each column in 50 ml ultrapure
water. DNA recovered from both digests was pooled to obtain approximately 20–30 mg.
A total of 14 mg of DNA were used as template in the subsequent LAM-PCR reaction, initiated
from a 5’ biotinylated primer specific to a unique viral packaging signal in the GT sequence, and
elongating through the adjacent proviral LTR into the flanking sequence in the genome. Seven repli-
cate reactions were set up, each containing 2 mg of DNA, 0.5 pmol of the primer 3LTRflanking-biot1
(5’-GGTCTCCAAATCTCGGTGGAAC-3’), 1X AccuPrime PCR Buffer II and 0.4 ml AccuPrime Taq
DNA Polymerase, High Fidelity (Thermo Fisher Scientific Cat. # 12346) in a total volume of 50 ml. The
following PCR program was run: (5 min at 95˚C) x 1 cycle; (30 s at 95˚C, 30 s at 58˚C, 60 s at 68˚C) x
100 cycles. After the first 51 cycles, the reaction was paused and another 0.4 ml of AccuPrime Taq
DNA Polymerase were added to each reaction. A control reaction containing 2 mg of digested DNA
from unmutagenized cells lacking the provirus was run in parallel.
The resulting PCR product from each replicate LAM-PCR reaction was purified on 8 ml of mag-
netic Dynabeads M280 (Dynabeads kilobaseBINDER Kit, Thermo Fisher Scientific Cat. # 60101). The
beads were prewashed three times with 100 ml PBS and once with 20 ml of the Binding Solution
included in the kit, using a multi-well magnet. The beads were resuspended in 50 ml Binding Solu-
tion, and each 50 ml LAM-PCR reaction was added and mixed thoroughly to resuspend the beads.
Reactions were incubated overnight at RT with gentle rotation to capture the biotinylated PCR prod-
uct on the streptavidin-coated beads.
A 5’ phospho, 3’ dideoxy DNA linker (5’-TCGTATGCCGTCTTCTGCTTGACTCAGTAGTTG
TGCGATGGATTGATG-3’) complementary to a Solexa adaptor sequence (see below) was appended
to the 3’ end of each amplicon using the CircLigase II ssDNA ligase (Epicentre, Cat. # CL9025K). The
3’ dideoxy modification on the linker prevents self-ligation, while the biotinylated 5’ end of the LAM-
PCR product prevents amplicon multimerization. The beads were washed three times with 100 ml
PBS (excess buffer was carefully removed), resuspended thoroughly in 20 ml of a reaction containing
25 pmol of DNA linker, 1X CircLigase II reaction buffer, 2.5 mM MnCl2, 1 M Betaine and 0.75 ml Cir-
cLigase II ssDNA Ligase, and incubated at 60˚C for 1 hr.
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The LAM-PCR product comprising genomic sequence flanked by the LTR junction on the 5’ end
and by the linker on the 3’ end was amplified exponentially using complementary primers containing
Solexa adaptor sequences, LTRSolexaI (5’-AATGATACGGCGACCACCGAGATCTGATGGTTCTC
TAGCTTGCC-3’) and Solexa adaptor II (5’-CAAGCAGAAGACGGCATACGA-3’). The beads were
washed three times with 100 ml PBS (excess buffer was carefully removed) and resuspended thor-
oughly in 50 ml of a reaction containing 25 pmol of each primer, 1X AccuPrime PCR Buffer II and 0.6
ml of AccuPrime Taq DNA Polymerase, High Fidelity. The following PCR program was run: (2 min at
95˚C) x 1 cycle; (30 s at 95˚C, 30 s at 55˚C, 90 s at 68˚C) x 35 cycles; (7 min at 68˚C) x 1 cycle. Tubes
were centrifuged briefly to recover the solution and pellet the beads, and the supernatant was
removed for analysis and final PCR product purification.
8 ml of the PCR product was analyzed on a 2% agarose diagnostic gel, along with the control
reaction prepared from unmutagenized cells. A smear between 100 and 500 base pairs (bp) is typi-
cally visible for reactions from GT-mutagenized DNA, indicative of a successful library preparation,
but not for the control reaction from unmutagenized DNA. Successful reactions were pooled, and
the final PCR product from 100 ml of solution was purified using the QIAquick PCR Purification Kit
and eluted in 50 ml of ultrapure water. A 10 nM solution of the product (the concentration was calcu-
lated using an estimated average PCR product size of 360 bp) was sequenced on one lane of an Illu-
mina Genome Analyzer IIx using a custom sequencing primer specific to the outer extreme end of
the LTR (SolexaseqFlank: 5’-CTAGCTTGCCAAACCTACAGGTGGGGTCTTTCA-3’), resulting in 36 bp
reads of the sequence directly flanking GT insertion sites. FASTQ files containing the sequencing
data for unsorted (control) and sorted cells from each screen have been deposited in the National
Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) with Study
accession number SRP094861.
Mapping of sequencing reads and statistical analysis of GT
insertion enrichment
GT insertions were mapped as described previously (Carette et al., 2011a). Briefly, the 36 bp
sequences in the FASTQ sequencing data files were aligned to the human genome version 18 (hg18)
using Bowtie alignment software (Langmead et al., 2009). To generate a dataset of unique GT
insertion sites, we excluded ambiguous alignments (no mismatches in the full 36 bp sequence were
allowed) and sequences that aligned non-uniquely to the human genome. Furthermore, the
sequence was required to align uniquely to the human genome even when 1 or 2 mismatches were
allowed, and if two sequences aligned 1 or 2 base pairs apart, only one was retained.
For each screen, insertions mapped to genes in the sorted cells were compared to those in the
unsorted control population. The number of insertions per gene was determined by intersecting
each dataset of unique insertion sites with a list of the chromosomal coordinates of RefSeq-anno-
tated genes. If an insertion was located in a genomic region shared by multiple transcripts of the
same gene, it was only counted once. GT insertions in annotated genes were classified as being in
the sense or antisense orientation relative to the coding sequence of the gene, and as being in
exons or introns. For the unsorted (control) cells, the number of GT insertions in each gene (regard-
less of orientation), and the total number of insertions for all genes was determined. For the sorted
cells, the number of inactivating GT insertions in each gene, defined as sense and antisense inser-
tions in exons and sense insertions in introns, and the total number of inactivating insertions for all
genes was determined. Enrichment of GT insertions for a given gene was calculated by comparing
the relative frequency at which that gene harbored inactivating GT insertions in the sorted cells com-
pared to the relative frequency at which the gene carried any GT insertion in the control dataset. For
each gene, a p-value was calculated using the one-sided Fisher exact test and was corrected for false
discovery rate (FDR) (see Supplementary file 1).
Comparative analysis of significant hits across screens
The FDR-corrected p-value for enrichment of GT insertions in the sorted compared to the control
cells depends on many experimental variables affecting both datasets, making it an equivocal metric
to directly compare hits between screens. We therefore developed an additional scoring metric that
depends only on the dataset for the sorted cells. It relies on the fact that generally only sense GT
insertions in introns should inactivate genes due to the directionality of the splice acceptor in the
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GT, and it captures the relative abundance of intronic GT insertions in the sense and antisense orien-
tations, as well as the overall number of intronic insertions. We defined the Intronic GT Insertion Ori-
entation Bias (IGTIOB) score as log2(S/A) x ln(S x A), where ‘S’ and ‘A’ equal one plus the number of
unique sense or antisense intronic GT insertions, respectively, in a given gene. High, positive IGTIOB
scores generally indicate genes whose disruption promotes the phenotype enriched for during the
screen.
To compare hits between screens, we first generated a list of genes including only those with a
stringent GT enrichment FDR-corrected p-value<10 4 in at least one of the screens being
considered Supplementary file 3. We then used the IGTIOB scores of those genes in all the relevant
screens to build a heat map (Figures 4B and 5D). Genes were clustered using the absolute value/
city block setting and complete linkage method (without normalization) in the hierarchical clustering
tool of the Partek Genomics Suite software, and the data range was adjusted to encompass only
non-negative IGTIOB scores (i.e. negative values were displayed as 0). Groups of genes preferen-
tially enriched for GT insertions in one or more screens (as determined by visual inspection) are indi-
cated next to the heat maps.
Construction of mutant HAP1-7TGP cell lines by CRISPR/Cas9-mediated
genome editing
Oligonucleotides encoding single guide RNAs (sgRNAs) (Supplementary file 4) were selected from
a published library (Shalem et al., 2014), or designed using either of two online CRISPR design tools
(Hsu et al., 2013; Doench et al., 2014) and cloned into pX330 according to a published protocol
(original version of ‘Target Sequence Cloning Protocol’ from http://www.genome-engineering.org/
crispr/wp-content/uploads/2014/05/CRISPR-Reagent-Description-Rev20140509.pdf; Cong et al.,
2013).
Clonal HAP1-7TGP cell lines were established by transient transfection with pX330 containing the
sgRNA followed by single cell sorting as follows. A transfection mix was prepared by diluting 450 ng
of pX330 and 50 ng of pmCherry (used as a co-transfection marker for FACS sorting) in 48 ml Opti-
MEM I, adding 2 ml of X-tremeGENE HP and incubating for 20 min at RT. HAP1-7TGP cells or deriva-
tives thereof were reverse-transfected in a well of a 24-well plate by overlaying 0.5 ml of CGM 2
(without antibiotics) containing 6  105 cells over the 50 ml of transfection mix. Cells were passaged
to a 10 cm dish ~24 hr post-transfection, using 150 ml of Trypsin-EDTA (0.25%) (Thermo Fisher Scien-
tific Cat. # 25200056) to detach them (reverse-transfection of HAP1 cells caused unusually high
adherence, hence the higher trypsin concentration). Four to five days post-transfection, single trans-
fected (mCherry-positive) cells were sorted into 96-well plates containing 200 ml of CGM 2 per well
and grown undisturbed for 16 to 17 days. Single colonies were passaged to 24-well plates, and a
small number of cells was reserved for genotyping.
For genotyping, genomic DNA was extracted by adding 4 volumes of QuickExtract DNA Extrac-
tion Solution (Epicentre Cat. # QE09050) to the cells. Extracts were incubated 10 min at 65˚C, 3 min
at 98˚C, and 5 ml were used as input for PCR amplification of the sgRNA target site in 15 ml reactions
containing 1X LongAmp Taq reaction buffer, 300 mM of each dNTP, 400 nM of each of the flanking
primers indicated in Supplementary file 4 (most of them designed using the Primer-BLAST online
tool from the NCBI) and 0.1 units/ml of LongAmp Taq DNA polymerase (NEB Cat. # M0323L). The
presence of desired mutations was initially assessed by analysis of the PCR products on a 1% aga-
rose gel (i.e. the absence of an amplicon or a shift in its size was deemed indicative of a lesion) and
was confirmed by sequencing the amplicons using the primers indicated in Supplementary file 4.
Given that most engineered cell lines remained haploid, sequencing results were usually unequivo-
cal. A summary of the sequencing results for all clonal cell lines used in the study is presented in
Supplementary file 2, and for selected clonal cell lines immunoblot analysis of the protein products
is presented in Figures 2C, 6D and H, Figure 3—figure supplement 1A and Figure 5—figure sup-
plement 1A.
Whenever possible, multiple independent mutant cells lines, often generated using two different
sgRNAs (see Supplementary file 2), were expanded and used for further characterization. For some
of the comparisons between WT and mutant cells, multiple individual cell lines confirmed by
sequencing to be WT at the sgRNA target site were also expanded and used as controls. To gener-
ate double and triple mutant cell lines, a single clonal cell line with the first desired mutation was
used in a subsequent round of transfection with pX330 containing the second and, if applicable,
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third sgRNAs. Alternatively, WT HAP1-7TGP cells were directly transfected with a combination of
pX330 constructs targeting two genes simultaneously. To facilitate screening of mutant clones by
PCR when targeting two genes simultaneously, we sometimes targeted one of them at two different
sites within the same exon or on adjacent exons and amplified genomic sequence encompassing
both target sites. Mutant clones were readily identified by the reduced size of the resulting ampli-
con, and the precise lesion was confirmed by sequencing.
Isolation of APCKO-2 mutant cell line containing a GT insertion
As an alternative to CRISPR/Cas9-mediated genome editing, a mutant cell line containing a GT
insertion in APC was isolated as follows. Mutagenized HAP1-7TGP cells enriched during the WNT-
negative regulator screen (Figure 1C) were used to isolate the APCKO-2 clone. Following the screen,
the same FACS gate used during the screen was used to sort single cells into 96-well plates.
Colonies were harvested after 16 days, 1/10th of each clone was passaged for continued growth,
and the remainder of the cells from adjacent pairs of rows in each plate were pooled. A portion of
all the cells from pairs of plates were further pooled so as to obtain ‘plate-pair’ pools, and ‘row-pair’
sub-pools. Cells from plate-pair pools were harvested by centrifugation, genomic DNA was pre-
pared using the QIAamp DNA mini kit and each pool was probed for clones containing GTs in APC
using a nested PCR strategy. A genomic region of APC enriched for GT insertions was amplified by
PCR using a forward primer complementary to a unique sequence in the GT (pGT-Puro4: 5’-TC
TCCAAATCTCGGTGGAAC-3’) and a reverse primer complementary to a unique genomic sequence
adjacent to the GT-enriched region in APC (APC_GT: 5’-TGCTACAATGAGCTGTTAAAATGG-3’).
400 ng of genomic DNA was used as input for PCR amplification in 25 ml reactions containing 1X
LongAmp Taq reaction buffer, 300 mM of each dNTP, 400 nM of each primer and 0.1 units/ml of
LongAmp Taq DNA polymerase. For each plate-pair pool, the presence of clones containing a GT
insertion was evident as discrete bands when the PCR products were analyzed on a 1% agarose gel.
Once positive plate-pair pools were identified, genomic DNA from the corresponding row-pair
sub-pools was prepared using QuickExtract DNA Extraction Solution and the PCR procedure was
repeated to identify row pairs containing clones with GT insertions. Finally, the individual clonal cell
lines that had been passaged were harvested from the 96-well plates containing GT-positive row
pairs, and GT-containing clones were identified using the same procedure. To map the precise
genomic location of the GT insertion in APCKO-2 (see Supplementary file 2), the final PCR product
obtained from an individual GT-positive clone was sequenced.
Rescue of TFAP4CR-1 cells
Rescue of TFAP4CR-1 cells and overexpression of TFAP4 in WT HAP1-7TGP cells (Figure 2B) was
done by transient transfection. TFAP4CR-1and HAP1-7TGP were reverse-transfected in a well of a 24-
well plate by overlaying 0.5 ml of CGM 2 (without antibiotics) containing 6  105 cells over 50 ml of a
transfection mix containing 450 ng of pCSDest-TFAP4 or pCS2+ (vector control) and 50 ng of
pmCherry (as a co-transfection marker for FACS analysis) in Opti-MEM I, and 2 ml of X-tremeGENE
HP. Cells were harvested using 150 ml of Trypsin-EDTA (0.25%) and passaged to a 6 cm dish ~24 hr
post-transfection. ~48 hr post-transfection cells were treated for 16–24 hr with 50% WNT3A CM
where indicated, and the WNT reporter (EGFP) fluorescence of mCherry-positive, singlet-gated cells
was measured by FACS.
Epistasis analysis in TFAP4CR-1 cells
Epistasis analysis in WT HAP1-7TGP and TFAP4CR-1 cells (Figure 2D) was done following treatment
with WNT3A, the GSK3 inhibitor LiCl, or following transient transfection with dominant negative
CTNNB1 (S33Y mutant) as follows. WT HAP1-7TGP and TFAP4CR-1 cells were treated for 16–24 hr
with 50% WNT3A CM or with 40 mM LiCl in CGM 2 where indicated, and the WNT reporter fluores-
cence of singlet-gated cells was measured by FACS. Alternatively, WT HAP1-7TGP and TFAP4CR-1
cells were reverse transfected with pCS2+ (vector control) or pCS2-b-cat-S33Y and pmCherry (as a
co-transfection marker for FACS analysis) as described in the previous section. Cells were
passaged ~24 hr post-transfection, and ~48 hr post-transfection the WNT reporter (EGFP) fluores-
cence of mCherry-positive, singlet-gated cells was measured by FACS.
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Quantitative RT-PCR analysis
Approximately 24 hr before treatment, cells were seeded in 24-well plates at a density of 2  105
per well and grown in 0.5 ml of CGM 2. Cells were treated for 12 hr with 50% WNT3A CM in CGM 2
where indicated. The medium was removed, and cells were harvested without washing in 800 ml of
TRIzol Reagent (Thermo Fisher Scientific Cat. # 15596018). Extracts were processed according to
the manufacturer’s protocol taking the appropriate precautions to avoid contamination with nucle-
ases, and total RNA was resuspended in 40 ml of DEPC-treated water (Thermo Fisher Scientific Cat.
# AM9920). To synthesize cDNA, 250 ng of RNA were diluted in 8 ml DEPC-treated water, 2 ml of 5X
iScript Reverse Transcrition Supermix for RT-qPCR (Bio-Rad Cat. # 170–8841) were added, and the
reaction was incubated 5 min at 25˚C, 30 min at 42˚C and 5 min at 85˚C. cDNA was diluted 1:100 in
water, and 5 ml were mixed with 5 ml of iTaq Universal SYBR Green Supermix (Bio-Rad Cat. # 172–
5121) containing 400 nM each of forward and reverse primer (hAXIN2-RT-PCR-1-FOR: 5’-GTCCAG-
CAAAACTCTGAGGG-3’, hAXIN2-RT-PCR-1-REV: 5’-CTGGTGCAAAGACATAGCCA-3’; hCTNNB1-
RT-PCR-1-FOR: 5’-AAAGCGGCTGTTAGTCACTGG-3’, hCTNNB1-RT-PCR-1-REV: 5’-CGAGTCA
TTGCATACTGTCCAT-3’; hHPRT1-RT-PCR-1-FOR: 5’-TGCTGAGGATTTGGAAAGGG-3’, hHPRT1-
RT-PCR-1-REV: 5’-ACAGAGGGCTACAATGTGATG-3’). Triplicate reactions for each cDNA and
primer pair were prepared in a MicroAmp Optical 384-well Reaction Plate (Thermo Fisher Scientific
Cat. # 4309849), sealed with MicroAmp Optical Adhesive Film (Thermo Fisher Scientific Cat. #
4311971) and run using standard parameters in an ABI 7900 Fast Real-Time PCR system (Applied
Biosystems) controlled by the Sequence Detection Systems software version 2.4.1 provided by the
manufacturer. The formula 2-DCt was used to calculate the average relative abundance of AXIN2
(Figures 2A, 6B and F and Figure 6—figure supplement 1A and E) or CTNNB1 (Figure 6—figure
supplement 1C) mRNA normalized to HPRT1 mRNA, and fold-changes in mRNA abundance were
calculated as the quotient between the experimental and reference samples, with appropriate error
propagation of the respective standard deviations (SD).
Immunoblot analysis of HAP1-7TGP and mutant cell lines
Quantitative immunoblot analysis of soluble CTNNB1 from membrane-free
supernatant (MFS) (Figures 2C, 3D,F, 6C,D,G and H, Figure 3—figure
supplement 1C and Figure 6—figure supplement 1B and F)
Approximately 24 hr before treatment cells were seeded in 6 cm dishes at a density of 4  106 per
dish and grown in 6 ml of CGM 2. Cells were treated for 10 hr with 50% WNT3A CM or 10 mM of
the GSK3 inhibitor CHIR-99021 in CGM 2 where indicated. Cells were harvested, lysed by hypotonic
shock, and extracts were prepared as follows, with all handling done on ice or at 4˚C. Cells were
washed twice with ~5 ml cold PBS and twice with ~5 ml cold 10 mM HEPES pH 7.4. Residual buffer
was removed, and 100 ml of ice cold SEAT buffer (10 mM triethanolamine/acetic acid pH 7.6, 250
mM sucrose, 1X SIGMAFAST Protease Inhibitor Cocktail Tablets EDTA-free (Sigma-Aldrich Cat. #
S8830), 25 mM MG132 (Sigma-Aldrich Cat. # C2211), 1X PhosSTOP (Roche Cat. # 04906837001), 1
mM NaF, 1 mM Na3VO4, 1 mM dithiothreitol (DTT), 62.5 U/ml Benzonase Nuclease (EMD Millipore
Cat. # 70664), 1 mM MgCl2) were added to the cells. Cells were scraped using a cell lifter (Corning
Cat. # 3008), transferred to 2-ml centrifuge tubes and disrupted mechanically by triturating 10 times.
Crude extracts were centrifuged for 20 min at 20,000 x g to pellet membranes and nuclei, and the
membrane-free supernatant (MFS) was carefully removed, avoiding contamination from the pellet.
The MFS was flash-frozen in liquid nitrogen and stored at  80˚C until further processing.
Extracts were thawed quickly at RT and transferred to ice. The protein concentration in the MFS
was quantified with the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific Cat. # 23225), using
BSA as a standard, and samples were normalized by dilution with SEAT buffer. The MFS was diluted
with 4X LDS sample buffer (Thermo Fisher Scientific Cat. # NP0007) supplemented with 50 mM tris
(2-carboxyethyl)phosphine (TCEP), heated for 5 min at 95˚C, and 30 mg of total protein were electro-
phoresed alongside Precision Plus Protein All Blue Prestained Protein Standards (Bio-Rad Cat. #
1610373) in NuPAGE 4–12% Bis-Tris gels (Thermo Fisher Scientific, various Cat. numbers) using 1X
NuPAGE MOPS SDS running buffer (Thermo Fisher Scientific Cat. # NP0001), or on 8% Tris-poly-
acrylamide home-made gels using Tris-glycine SDS running buffer (25 mM Tris, 192 mM glycine,
0.1% SDS).
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Proteins were transferred to nitrocellulose membranes in a Criterion Blotter apparatus (Bio-Rad
Cat. # 1704071) using 1X NuPAGE transfer buffer (Thermo Fisher Scientific Cat. # NP0006) + 10%
methanol for Bis-Tris gels, or Tris-glycine wet transfer buffer (12 mM Tris, 96 mM Glycine, 10% meth-
anol) for Tris-polyacrylamide gels. Membranes were cut, blocked with Odyssey Blocking Buffer, incu-
bated with mouse anti-b-catenin, mouse anti-GAPDH or mouse anti-ACTIN primary antibodies,
washed with TBST, incubated with IRDye 800CW donkey anti-mouse IgG secondary antibody,
washed with TBST followed by TBS, and imaged using the Li-Cor Odyssey imaging system. Acquisi-
tion parameters in the manufacturer’s Li-Cor Odyssey Image Studio software were set so as to avoid
saturated pixels in the bands of interest, and bands were quantified using manual background sub-
traction. The integrated intensity for CTNNB1 was normalized to that for GAPDH or ACTIN in the
same blot, and the average ± SD from duplicate blots was used to represent the data, except for
the TFAP4 experiment shown in Figure 2C, for which only one blot was analyzed.
Other immunoblot analyses of MFS (Figures 2C, 6D and H and Figure 5—
figure supplement 1A)
The same membrane probed for GAPDH in the experiment shown in Figure 2C was subsequently
incubated with rabbit anti-AP4 (TFAP4). The same membranes or duplicates of the ones probed for
GAPDH in the experiments shown in Figure 6D and H were subsequently incubated with rabbit
anti-SERBP1 or goat anti-casein kinase 1a primary antibodies, respectively. The same membrane
probed for CTNNB1 in the experiment shown in Figure 6D was subsequently incubated with rabbit
anti-APC. Following washes, the blots were incubated with IRDye 680RD donkey anti-rabbit IgG,
peroxidase AffiniPure donkey anti-goat IgG, or peroxidase AffiniPure goat anti-rabbit IgG secondary
antibodies, as appropriate. The TFAP4 and SERBP1 blots were imaged using the Li-Cor Odyssey
imaging system, and the CSNK1A1 and APC blots were developed using the SuperSignal West
Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific Cat. # 34095).
To probe for HUWE1 (~480 kDa, Figure 6H) the same extracts used to quantify CTNNB1 in
Figure 6H were electrophoresed in a 4% Tris-polyacrylamide gel strengthened with 0.5% agarose
(based on the protocol of Kinoshita et al., 2009) using Tris-glycine SDS running buffer. Proteins
were transferred to nitrocellulose membranes using Tris-glycine wet transfer buffer, blocked with
TBST + 5% skim milk, and incubated with rabbit anti-Lasu1/Ureb1 (HUWE1) primary antibody, fol-
lowed by peroxidase AffiniPure goat anti-rabbit IgG secondary antibody. The membrane was devel-
oped using the SuperSignal West Femto Maximum Sensitivity Substrate.
Immunoblot analysis of total AXIN1 and AXIN2 (Figure 3—figure
supplement 1A)
Approximately 24 hr before treatment, cells were seeded in 6 cm dishes at a density of 4  106 per
dish, and grown in 6 ml of CGM 2. Cells were treated with 10 mM CHIR-99021 in CGM 2 for 14 hr to
induce expression of AXIN2. Cells were harvested in 1 ml Trypsin-EDTA (0.05%), resuspended in 3
ml CGM 2, centrifuged at 400 x g for 5 min, washed in 1.9 ml PBS, transferred to 2-ml centrifuge
tubes and centrifuged at 800 x g for 5 min. The supernatant was aspirated and the cell pellets were
flash-frozen in liquid nitrogen and stored at  80˚C. Pellets were thawed quickly at RT and trans-
ferred to ice. All subsequent steps were done on ice or at 4˚C. The cell pellets were resuspended in
150 ml of ice-cold RIPA lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2% NP-40, 0.25% deoxy-
cholate, 0.1% SDS, 1X SIGMAFAST protease inhibitors, 1 mM MgCl2, 62.5 U/ml Benzonase Nucle-
ase, 1 mM DTT, 10% glycerol), sonicated in a Bioruptor 300 (Diagenode) 4  30 s in the high
setting, centrifuged 10 min at 20,000 x g and the supernatant was recovered.
The protein concentration in the supernatant was quantified using the Pierce BCA Protein Assay
Kit. Samples were normalized by dilution with RIPA lysis buffer, further diluted with 4X LDS sample
buffer supplemented with 50 mM TCEP, heated for 5 min at 95˚C, and 100 mg of total protein were
electrophoresed alongside Precision Plus Protein All Blue Prestained Protein Standards in NuPAGE
4–12% Bis-Tris gels using 1X NuPAGE MOPS SDS running buffer.
Proteins were transferred to nitrocellulose membranes using 1X NuPAGE transfer buffer + 10%
methanol, and membranes were cut and blocked with TBST + 5% skim milk. Blots were incubated
with goat anti-AXIN1, rabbit anti-AXIN2 or mouse anti-GAPDH primary antibodies, washed with
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TBST, incubated with Peroxidase AffiniPure anti-goat, anti-rabbit or anti-mouse secondary antibod-
ies, washed with TBST followed by TBS, and developed with SuperSignal West Femto.
Immunofluorescence of HAP1-7TGP and mutant cell lines
CTNNB1 immunostaining (Figure 3—figure supplement 2B–2F)
Approximately 24 hr before treatment, cells were seeded at a density of 4  104 per well on Poly-L-
Lysine-coated #1 12 mm round coverslips placed in 24-well plates, and were grown in 0.5 ml of
CGM 2. Cells were treated for 4 hr (or the periods indicated in the time-course experiment depicted
in Figure 3—figure supplement 2A) with CGM 2 or with 50% WNT3A CM in CGM2 where indi-
cated. Following treatment, the medium was removed, and cells were washed once with PBS and
fixed with 4% paraformaldehyde in PBS for 10 min. Fixed cells were washed with PBS 3  5 min,
blocked with blocking solution (PBS, 0.5% Triton X-100, 3% BSA) for 30 min and stained with mouse
anti-b-catenin in blocking solution for 30 min at RT. Cells were washed with PBS 3  5 min and
stained with donkey anti-mouse IgG (H+L) Alexa Fluor 647 conjugate in blocking solution for 30 min
at RT. Cells were washed with PBS 3  5 min and mounted on slides using ProLong Diamond Anti-
fade Mountant with DAPI (Thermo Fisher Scientific Cat. # P36962). Fluorescence micrographs were
acquired on a Leica SP8 laser scanning confocal microscope equipped with a 63X oil immersion
objective (NA 1.4) and an HyD hybrid detector, using Leica Application Suite X (LASX) software. Dur-
ing a given experiment, all Z-stacks were acquired with identical settings (laser power, gain, offset,
frame format). Confocal sections were viewed and exported as TIF files using Volocity 6.3 (Perki-
nElmer), adjusted equally for contrast and brightness when necessary for clarity using Photoshop
CS5 (Adobe), and arranged in Illustrator CS5 (Adobe).
Quantification of nuclear CTNNB1 (Figure 3E and F and Figure 3—figure
supplement 2A)
Leica Image Files (LIF) were converted into MATLAB matrices (MAT) in Volocity 6.3 (PerkinElmer).
Matrices were manually curated to remove out-of-focus optical planes and analyzed using MATLAB
R2014b (MathWorks) to determine the mean fluorescence intensity of nuclear CTNNB1 staining.
Briefly, the fluorescence values from the DAPI channel were smoothed using a low-pass Gaussian fil-
ter to remove fine noise, and a threshold was applied to generate a nuclear mask. The nuclear mask
was eroded uniformly to prevent contamination with cytoplasmic signal and optical sections with
poor nuclear masks were discarded. The fluorescence values from the irrelevant pool of CTNNB1 at
tight junctions were removed from the CTNNB1 channel in each plane using a high-pass Gaussian fil-
ter. The sum of the corrected fluorescence intensity values from the CTNNB1 channel co-localizing
with the nuclear mask were divided by the nuclear mask area to obtain the mean nuclear fluores-
cence per unit area for each optical plane. The final reported value for each field of view, referred to
as ‘nuclear CTNNB1’, is the median of the mean nuclear fluorescence per unit area obtained from
the three most central optical sections. The graphs presented in Figure 3E and Figure 3—figure
supplement 2A display the average (± SD) nuclear CTNNB1 from two or three fields of view.
Xenopus laevis body axis duplication assay
mRNA was synthesized using the mMESSAGE mMACHINE SP6 Kit (Thermo Fisher Scientific Cat. #
AM1340) from a pCSDest-based construct containing the CDS encoding the protein of interest.
One microgram of plasmid DNA was linearized and mRNA was synthesized according to the proto-
col provided by the manufacturer. The mRNA was treated with TURBO DNase and purified using
the RNeasy Mini Kit (QIAGEN Cat. # 74104), following the ‘RNA cleanup’ protocol. The purified
product was analyzed on a 1% agarose gel. X. laevis eggs were fertilized, de-jellied with L-cysteine,
and equilibrated in Marc’s Modified Ringers (MMR: 0.1 M NaCl, 2 mM KCl, 1 mM MgSO4, 2 mM
CaCl2, 5 mM HEPES pH 7.8, 0.1 mM EDTA) containing 2% Ficoll. One ventral blastomere of four-cell
stage embryos was injected with 3 nl of a 1.67 ng/nl mRNA solution (5 ng total) using an MPPI-2
Pressure Injector (Applied Scientific Instrumentation). Embryos were incubated at RT in 1/3 MMR
until stage 34 and scored for body axis duplication (Figure 2F) on a Zeiss Stemi 2000-C stereo
microscope. Embryos were fixed overnight in MEMFA buffer (100 mM MOPS, 2 mM EGTA, 1 mM
MgSO4, 3.7% formaldehyde) transferred to 100% glycerol and images (Figure 2E) were taken with
an Olympus DP72 camera at 2.5X magnification.
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Drosophila melanogaster methods
Flies and transgenes
The driver C765-Gal4 (BDSC) was used for all crosses. All experiments were performed at 25˚C.
pUASTattB-Axin-V5 was generated as described previously (Yang et al., 2016). To generate the
pUASTattB-AxinDC-V5 transgene, residues 705 through 745 were deleted by PCR-based mutagene-
sis of pUASTattB-Axin-V5 using the oligonucleotide 5’-GGTCACTTTAGGAAGCTTGGTAAACC-3’.
The resulting AxinDC-V5 fragment was digested with KpnI and HindIII, and cloned into the pUAS-
TattB vector digested with the same enzymes. Transgenic flies were generated using site-specific
integration at the attP33 site using phiC31-based integration (Bischof et al., 2007).
Imaging of adult fly wings (Figure 3G)
Images of adult fly wings were acquired with a Nikon E800 Epifluorescence microscope using Olym-
pus DP software.
Immunostaining of wing imaginal discs (Figure 3—figure supplement 3B)
Third instar larval wing imaginal discs were dissected in PBS, fixed with 4% paraformaldehyde in PBS
for 20 min, washed with PBS + 0.1% Triton X-100, and incubated in blocking solution (PBS, 0.5% Tri-
ton X-100, 10% BSA) for 1 hr. Imaginal discs were incubated with anti-Senseless or anti-Wingless pri-
mary antibodies in PBS + 0.5% Triton X-100 overnight at 4˚C, and with appropriate secondary
antibodies for 2 hr at RT. Fluorescence images were acquired using a Nikon A1RSi confocal micro-
scope and processed using Photoshop CS5 (Adobe).
Immunostaining of embryos (Figure 3—figure supplement 3C)
Embryos were fixed in 3.7% formaldehyde (Vorwald-Denholtz and De Robertis, 2011) and rehy-
drated in PBT (PBS, 1% BSA, 0.1% Tween-20). Following incubation for 1 hr in blocking solution
(PBS, 10% BSA, 0.1% Tween-20), embryos were incubated with mouse anti-Engrailed/Invected or
mouse anti-Wingless primary antibodies in PBT overnight at 4˚C. After washing with PT (PBS, 0.1%
Tween-20), embryos were incubated for 1 hr with donkey anti-mouse IgG (H+L) Alexa Fluor 555 sec-
ondary antibody for 1 hr at RT. Embryos were then washed with PT and mounted in ProLong Gold
Antifade Mountant (Thermo Fisher Scientific Cat. # P10144). Fluorescence images were acquired on
a Nikon NIS confocal microscope, processed using Photoshop CS5 (Adobe) and assembled using
Illustrator CS5 (Adobe).
Immunoblotting of embryonic lysates (Figure 3—figure supplement 3E)
Embryos were lysed in lysis buffer (50 mM Tris-HCl pH 8.0, 100 mM NaCl, 1% NP-40, 10% glycerol,
1.5 mM EDTA pH 8.0, 1X Halt Protease and Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific
Cat. # 78440)). Lysates were fractionated on 8% SDS-PAGE, transferred to PVDF membranes and
blocked in TBST + 5% skim milk. Membranes were incubated with mouse anti-V5 or mouse anti-a-
Tubulin primary antibodies, washed with TBST, incubated with anti-mouse IgG HRP conjugated sec-
ondary antibody, washed, and developed using ECL reagent (250 mM luminol, 90 mM p-coumaric
acid, 100 mM Tris-HCl pH 8.5, 30% hydrogen peroxide). Protein levels were quantified by densitom-
etry of scanned film using Image J software (National Institutes of Health).
Cuticle preparations (Figure 3—figure supplement 3G)
Larval cuticles were prepared as described previously (Wieschaus and Nüsslein-Volhard, 1986).
Embryonic hatch rate determination (Figure 3—figure supplement 3H)
Fly eggs collected during a 1 hr period were incubated at 25˚C for an additional 24 hr before the
hatch rate was scored.
RNAseq analysis
Gene expression levels in WT HAP1 cells were determined from previously published data
(Dubey et al., 2016). Briefly, the raw RNAseq data for WT HAP1 cells (NCBI Gene Expression Omni-
bus (GEO) Series accession number GSE75515) was aligned, quantified and analyzed using Partek
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Flow software, version 4.0 (Partek Inc.). Reads were aligned to human reference genome build hg19
using the STAR Align and Quantify pipeline in Partek Flow. RPKM (Reads Per Kilobase of transcript
per Million mapped reads) normalization was used to obtain the values reported in Table 1. The nor-
malized data was imported into Partek Genomics Suite 6.6 software (Partek Inc.) to visualize the
quantification of normalized reads for selected genes, and Table 1 was assembled in Excel
(Microsoft).
Preparation of figures and statistical analysis
Illustrations were prepared using PowerPoint (Microsoft) and Illustrator CS6 (Adobe). Circle plots
depicting the hits from each screen, GT insertion histograms, dose response graphs, tables and sup-
plementary files were prepared using Excel (Microsoft). Bar and circle graphs were prepared using
Prism 6 (GraphPad Software) and statistical analysis was performed using the same software (details
of statistical tests used are given in the figure legends). Heat maps were generated using Partek
Genomics Suite 6.6 software (Partek Inc.) and finished in Illustrator CS6. FACS histograms and dot
plots were generated using FlowJo (FlowJo, LLC) and finished in Illustrator CS6. Pictures of immuno-
blots and model organisms were only adjusted for contrast and brightness when necessary for clarity
using Photoshop CS6 (Adobe), and were arranged in Illustrator CS6.
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. Supplementary file 1. Ranked lists of hits from all screens. Genes containing at least one GT inser-
tion in the population of sorted cells from each genetic screen described in this work are listed in
separate spreadsheets (the screen name is indicated on the tab of each spreadsheet), and are
ranked based on the significance of GT insertion enrichment (p-value) in the sorted vs. the unsorted
(control) cells. For the unsorted cells, the number of GT insertions in genes (regardless of orientation)
is indicated for the complete dataset and for each gene (column B). For the sorted cells, the number
of inactivating GT insertions in genes (sense and antisense insertions in exons and sense insertions in
introns), as well as the number of sense or antisense GT insertions in exons or in introns, is indicated
for the complete dataset and for each gene (columns C-G). Three measures of GT insertion enrich-
ment are shown: the p-value and the FDR-corrected p-value (both derived from columns B and C),
and the Intronic GT Insertion Orientation Bias (IGTIOB) score (derived from columns F and G). See
Materials and methods for details.
DOI: 10.7554/eLife.21459.018
. Supplementary file 2. List of clonal cell lines used in this study. Clones in which a single gene was
targeted using CRISPR/Cas9 or disrupted by a GT insertion, and double- or triple-mutant clones in
which multiple genes were disrupted using CRISPR/Cas9 or through a combination of CRISPR/Cas9
and a GT insertion are described in two separate spreadsheets labeled accordingly. For cell lines
engineered using CRISPR/Cas9, when more than one clone was generated using the same CRISPR
guide, the ‘Clone Name’ column indicates the generic name used throughout the manuscript to
describe the genotype, and the ‘Clone #’ column identifies the specific allele in each individual
clone. The ‘CRISPR guide’ column indicates the name of the guide used, which is the same as that of
the oligos encoding sgRNAs (see Materials and methods and Supplementary file 4). The ‘Genomic
Sequence’ column shows 80 bases of genomic sequence (5’ relative to the gene is to the left) sur-
rounding the target site. For each group of clones made using the same CRISPR guide (separated
by gray spacers), the ‘Genomic Sequence’ column is headlined by the reference WT genomic
sequence (obtained from RefSeq), with the guide sequence colored blue. The site of the double
strand cut made by Cas9 is between the two underlined bases. Sequencing results for individual
clones are indicated below the reference sequence. Some WT clones are indicated as such and were
used as controls. For mutant clones, mutated bases are colored red (dashes represent deleted
bases, three dots are used to indicate that a deletion continues beyond the 80 bases of sequence
shown, and large insertions are indicated in brackets), and the nature of the mutation, the resulting
genotype (with the mutated amino acid number specified in parenthesis for selected clones) and any
pertinent observations are also described. The figures in which each clone was used are also indi-
cated. For the APCKO-2 clone containing a GT insertion, the 80 bases of genomic sequence (5’ rela-
tive to the gene is to the left) flanking the GT are shown in the ‘Genomic Sequence’ column. For
double- or triple- mutant clones, the CRISPR guide or pair of guides used (if two different guides
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were used simultaneously to target adjacent sites in the same gene), the genomic sequence,
the mutation, the genotype and any observations pertaining to each of the two or three targeted
genes are designated ‘1’, ‘2’ and ‘3’ in the column headings, and are shown under green, orange
and purple spacers, respectively.
DOI: 10.7554/eLife.21459.019
. Supplementary file 3. Lists of the most significant hits included in comparative analyses across
screens. Genes used to generate the heat map (Figure 4B) comparing the two WNT positive regula-
tor screens (Figure 1E and F) and the low WNT + RSPO screen (Figure 4A) are shown in the first
spreadsheet, and those used to generate the heat map (Figure 5D) comparing the WNT positive
regulator, low stringency screen (Figure 1E) and the APC and CSNK1A1 suppressor screens
(Figure 5B and C) are shown in the second spreadsheet. Genes with an FDR-corrected p-value<10 4
in at least one of the three screens included in each comparison are shown, and the FDR-corrected
p-value and IGTIOB score for each gene in each screen is indicated. Genes are shown in the same
order as in the heat maps, clustered based on their IGTIOB scores (see Materials and methods for
details).
DOI: 10.7554/eLife.21459.020
. Supplementary file 4. List of oligonucleotides and primers used for generation and characterization
of clonal cell lines engineered using CRISPR/Cas9. The names and sequences of pairs of oligonucleo-
tides encoding sgRNAs (which were cloned into pX330) are shown in columns A and B, respectively.
The names and sequences of pairs of primers used to amplify corresponding genomic regions flank-
ing sgRNA target sites are shown in columns C and D, respectively. The names and sequences of sin-
gle primers used to sequence the amplified target sites are shown in columns E and F, respectively.
DOI: 10.7554/eLife.21459.021
Major datasets
The following dataset was generated:
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